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Abstract
Bacillus thermocatenulatus lipase (BTL2) is a thermostable enzyme with distinct tributyrin
selectivity and currently two different resolved structures are publicly available represent-
ing the; a) active-monomer form (PDB ID: 2w22) and b) inactive-dimer form (PDB ID:
1KU0). Using the information gained from these two structures, here we report the results
of two studies related to the protein engineering of BTL2 aiming to improve its chain-
length selectivity and to assess the impact of the lid tryptophans. For both of these studies,
the experimental approach was to generate specific BTL2 mutants for which site-directed
mutagenesis, heterologous protein expression and purification methodologies were used.In
the first study, a rational design of BTL2 was carried out to lower the activation barrier of
hydrolysis of short chain substrates. The results indicate that the mutant L360F optimizes
the physical and chemical interactions in BTL2 to lower the activation barrier for C4 and el-
evate it for C8 hydrolysis. For the second case, a semi-rational design was implemented to
investigate the impacts of the two tryptophans (W212, W235) in the lid of BTL2. W235A
affected tributyrin selectivity while W212A mutation is resulted in loss of the thermosta-
bility and aggregation tendency but also in the improvement of zinc tolerance in BTL2.
For this, it is envisioned that the aggregation of BTL2 is mediated through a zinc domain
and W212 is a secondary but vital residue for this action.
ii
Bacillus thermocatenulatus Lipazı U¨zerine
Protein Mu¨hendislig˘i C¸alıs¸maları
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O¨zet
Bacillus thermocatenulatus lipazı (BTL2) yu¨ksek tribu¨tirin sec¸icilig˘i olan thermokarar-
lı bir lipazdır ve yapısı aktif- monomer (PDB ID: 2w22) ve inaktif-dimer (PDB ID: 1KU0)
olarak atomistik detayda c¸o¨zu¨lmu¨s¸tu¨r. Burada, BTL2’nin protein mu¨hendislig˘i ile ilgili iki
vaka c¸alıs¸ması rapor edilmis¸tir. Protein mu¨hendislig˘inin rutin metotlarından olan yo¨nlendi-
rilmis¸ mutagenez, heterolog protein ekpressiyonu ve purifikasyon, bu tezdeki BTL2 ve mu-
tantları ic¸in yapılmıs¸tır. I˙lk olarak, kısa zincir boyundaki su¨bstratlara kars¸ı olan aktivasyon
bariyerini du¨s¸u¨rmek ic¸in BTL2’nin akılcı dizaynı gerc¸ekles¸tirilmis¸tir. So- nuc¸lar L360F
mutantının BTL2’deki aktivasyonu bariyerini C4 ic¸in du¨s¸u¨ren ve C8 ic¸in yu¨kselten bir mu-
tasyon oldug˘unu dog˘rulamıs¸tır. I˙kinci olarak, yarı-akılcı dizayn kullanarak BTL2’nin ka-
pak kısmında yer alan iki triptofan’nın (W212, W235) etkilerini incelemek ic¸in uygunlan-
mıs¸tır. O¨zellikle W212A, thermokararlılık ve agregasyon ac¸ısından ciddi bir du¨s¸u¨s¸ ve
c¸inko toleransı da bir artıs¸ go¨stermis¸tir. Bu ac¸ıdan, BTL2’nin agregasyonun c¸inko bag˘lanma
bo¨lgesi u¨zerinden gerc¸ekles¸tig˘ini ve W212 rezidu¨su¨nu¨n bu mekanizma ic¸in sekonder ama
elzem bir rolu ol- dug˘u o¨ngo¨ru¨lmektedir.
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1 LIPASES
1.1 Background
Lipases are metabolic enzymes found in every domain of life. They are produced by plants,
animals and microorganisms. The first discovery of lipases by Eijkmann dates back to
1900s. He observed that several bacteria can produce and secrete lipases to the extracellular
environments to degrade lipids. Considering the large variety of microbes known to human
today, microbial lipases are one of the most populated enzyme class and they have been
extensively studied with respect to enzyme promiscuity [1,2]. Lipases (EC 3.1.1.3, triacyl-
glycerol lipase) belong to hydrolases and they have become the objects of many successful
protein engineering approaches [3–10]. Additionally, a database has been established to
source the information on lipases engineering (http://www.led.uni-stuttgart.de/) [11]. As
lipases have been extensively studied, their mechanism of action, selectivity, structure and
kinetics are already determined and such information could be very useful in the context
of lipase engineering. Here, this chapter gives an overview of lipases.
1.2 Reactions
Lipases catalyze the breakdown of triacylglycerols (TAG) to free fatty acids (FA), diacyl-
glycerols (DAG), monoacylglycerols (MAG) and glycerol. This hydrolysis is an equilib-
rium reaction thus it can be perturbed by alteration of the concentration of substrates or
products. Water is one of the reactants of hydrolysis reaction and thus changing the hy-
drolytic conditions of the reaction shifts the equilibrium (e.g., low hydrolytic conditions
favor ester synthesis) [12].
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Figure 1.1:
Lipase-catalyzed reactions. Three main lipase reactions are shown and for all, first an
acyl-enzyme intermediate is formed, then this unstable intermediate collapses to free
enzyme and an acid in hydrolysis or an ester in esterification and transesterification. In
aqueous media, the equilibrium is towards ester hydrolysis and in dry media it is towards
ester synthesis. In organic solvents, lipase can catalyze acyl transfer reactions to
synthesize new esters.
Lipases act on carboxylic ester bonds, either by breaking as in hydrolysis or by forming
as in esterification and they also catalyze acyl transfer reactions through esterification.
Depending on the chemical nature of the reactants and water availability in the media,
different outcomes are possible yet, triacylglycerols (TAGs) are their natural substrates
[13]. A carboxyl/thiolester or amide can also be formed under low water conditions. An
ester group as an acyl donor can form the acyl-enzyme intermediate by either releasing an
acid -acyl acceptor is water- or forming a new ester -acyl acceptor is alcohol/thiol/amine-.
A summary of lipase-catalyzed reactions are shown in Figure 1.1. Acidolysis, alcoholysis,
interesterification and aminolysis are the examples to transesterification which is shown as
”esterification via acyl transfer” in Figure 1.1.
2
1.3 Mechanism
Despite the versatility of the reactions catalyzed by lipases, their reaction mechanism is
unique. The catalytic machinery is conserved in all lipases and is composed of three
residues: serine, histidine and aspartate/glutamate -identical to serine-proteases- [14]. Fig-
ure 1.2 illustrates the reaction mechanism of lipases in triacylglycerol hydrolysis. The
mechanism involves alignment of two residues (histidine and aspartate/glutamate) to lower
the pKa of the serine hydroxyl which enables serine to carry out a nucleophilic attack on
the ester bond.
According to Figure 1.2, the substrate which is an acyl donor contacts with the active
site of the lipase to form the enzyme-substrate (ES) complex, or the Michaelis complex in
honor of its founder. The histidine in the catalytic triad plays the role for a general base and
activates the hydroxyl group of serine. Serine is ready to carry out a nucleophilic attack on
the carbonyl carbon of the substrate to form the first tetrahedral intermediate. The negative
charge on the oxyanion is stabilized in the hole generated by the main-chain amide groups
of two residues and the positive charge on the histidine is stabilized by the aspartate or
glutamate of the catalytic triad. The tetrahedral intermediate decomposes into first leaving
group of the substrate, an alcohol, and the acyl enzyme intermediate.
After the formation of the acyl enzyme intermediate, a second tetrahedral intermediate
is formed which corresponds to the highest energy barrier in the reaction, similar to the
first intermediate (Figure 1.3). This intermediate is also collapsed to yield the deacylated-
free form of the enzyme which is ready for the next cycle and the hydrolysis of the second
substrate, an acid. During this deacylation step, a proton is transferred from the substrate
to histidine via serine oxygen.
3
Figure 1.2: Mechanism of Acylation.
4
Figure 1.3: Mechanism of Hydrolysis and Deacylation.
5
1.4 Selectivity
Lipase selectivity towards TAGs is usually distinguished as regio (related to the position
of the ester bond in TAG), stereo-selectivity (related to the chiral center) and substrate
selectivity (related to the type and chain-length) [15, 16].
1.4.1 Regio-selectivity
Also referred as positional selectivity, lipases are specific to the position of the ester bond
in TAG. In this regard, two conditions can be pictured as given in Figure 1.4. Some li-
pases can catalyze reactions of all hydroxyl groups and thus can release fatty acid at any of
the ester bonds in TAGs. These are referred as non-specific lipases and they can catalyze
complete breakdown of TAGs to glycerol and free fatty acids. Examples to this kind of
lipases are found in Burkholderia cepacia, Burkholderia glumae, Chromobactierum visco-
sum, Pseudomanos fluorescens [17, 18]. 1,3-specific lipases, on the other hand, catalyze
reactions of only primary hydroxyl groups of TAG (Figure 1.4). These lipases produce
free fatty acids, diacylglycerols and/or monoacylglycerols from 1- or 3- positions of TAG.
Most of the microbial lipases are 1,3-specific and examples to the lipase origin include
Bacillus thermocatenulatus, Aspergillus niger, Candidada antartica B, Rhizopus orzyae
and Mucor miehei [17–19]. In addition some lipase are found to be specific for certain
fatty acids and catalyze the esters formed from them. For instance the hydrolysis of only
long-chain fatty acids with a double bond between C9 and C10 is performed by the li-
pases from Geotrichium candidum and ungerminated oat seeds. These lipases can be also
referred as fatty acid specific lipases [19, 20].
1.4.2 Stereo-selectivity
Stereoselectivity refers to the selective formation of one stereoisomer (enantiomer or di-
astereomer) over another. Lipases may show insignificant stereo-specificity or they can
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Figure 1.4:
Regio-selectivity in TAG Hydrolysis. Non-specific lipases hydrolyze TAG completely to
produce free fatty acids and glycerol. 1,3-specific lipases catalyze the sn-1 and/or sn-3
ester linkages to a partial hydrolysis of triacylglycerols to free fatty acid, diacylglycerols
and monoacylglycerols.
be specific to either sn-1 or sn-3 hydroxyl groups of triacylglycerols [2]. Stereoselec-
tivity differ from lipase to lipase and from substrate to substrate for single lipase. Two
lipases from Pseudomonas sp. and Pseudomonas aeruginosa show high sn-1 preference
if the substrate is trioctanoin while most of the other microbial lipases exhibit moderate
stereo-selectivity towards trioctanoin. Candida antartica lipase B, on the other hand, has a
high stereo-selectivity towards sn-1 of trioctanoin but it changes to sn-3 preference when
triolein as substrate. In addition they can discriminate between R- or S- enantiomers of var-
ious esters. Both enantio- and regio-selectivities of lipases make them particular attention
for selective preparation of enantio-pure chemicals as well as selectively functionalized or
protected molecules [21, 22].
1.4.3 Substrate-selectivity
Lipases exhibit selectivity with respect to the type and the chain-length of the acyl groups
in their substrates. They can discriminate against certain fatty acids or groups of fatty acids.
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For example, porcine lipase is specific to cisc-2 over cis-7 octadecenoyl moiety [2]. More-
over, the lipase activity towards alcohols is shown to be in order as their most preferred
substrate is primary alcohols and the least preferred is tertiary alcohols [23]. Apart from
triacylglycerols and aliphatic esters, lipases can also accommodate cyclic esters, thioesters
and amines [18, 24, 25]. Additionally, the chain-length selectivity of lipases has been con-
sidered in several studies [26–29] and with respect to the chain-length of fatty acids, lipases
mostly prefer a range of medium (C6) to long (C16) chain-length [2]. However, few ex-
ceptions are encountered to this generalization and these include Penicillium roquefortti
and Bacillus thermocatenulatus lipases which hydrolyze only short chains of C4.
1.5 Structure
The first lipase structure has been crystallized in 1990 by Brady [14]. There are more than
one hundred of 3D lipase structures in protein data bank1. Based upon these studies, some
common structural features are found for all lipases. These can be listed as:
• All of the lipases are a member of α-β hydrolase fold such that lipase structures are
composed of central β sheets and surrounding α helices [30–33].
• The catalytic serine in all of the lipases are found in a hairpin turn between an α-helix
and α-helix or β -sheet. This region also contains a highly conserved penta-peptide
sequence of G-X-S-X-G which forms a characteristic turn that is also referred as
”nucleophilic elbow” [31, 32, 34].
• The active site in lipases is common to another class of hydrolases; serine-protease
which also consists of three amino acids, serine, histidine and aspartic/glutamic
acid [14, 35]. Although proteases and lipases share the same chemistry for active
1According to release statistics of PDB in 2012.
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site, the structural arrangement of the residues in active site is oriented to invert the
stereochemistry of the catalytic triad in lipases compared to proteases [36].
• An amphiphilic lid that covers the active site is found in lipases [37, 38]. The com-
position and size of the lid structure vary among other lipases. For instance, the lid
from the lipase of guinea pig has only five amino acids while the lid from Bacillus
thermocatenulatus lipase consists of two α-helices which corresponds to 20% of the
whole lipase structure [33, 39].
• The catalytic cleft of lipases is found to composed of four binding pockets, three
pockets holding sn-1, sn-2 and sn-3 acyl chains of triacylglycerol and an oxyanion
hole which is formed by the constellation of the amine groups to stabilize the tetra-
hedral anion during catalysis [40, 41].
Apart from these characteristics of lipase structures, the catalytic cleft in lipases are at-
tributed to specificity. Pleiss et al. investigated the lipase clefts, particularly the fatty
acid binding sites, and found that lipase structures may exhibit three different geometry;
crevice-like, funnel-like and tunnel-like [41]. These differences in the binding pockets
account for the diverse substrate specificities in lipases. In addition stereoselectivity in
lipases is dependent on the steric interaction of the cleft with the substrate and thus lipase
structure is also critical to understand the stereoselectivity [42].
1.6 Interfacial Activation
In 1958, Sarda and Desnuelle investigated the lipase activity and hypothesized ”interfacial
activation” of the lipase in the presence of water insoluble substrates through a conforma-
tional change in the lipase structure [43]. The direct evidence on the interfacial activation
was obtained from the crystallographic investigation of Rhizomucor miehei lipase com-
plexes with two different ligands [37, 44]. These lipase crystals that were captured in the
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activated form, are accepted as proofs for a conformational change in the surface loop with
respect closed structures revealing the structural basis of the interfacial activation. Follow-
ing this finding, a list of other lipases were crystallized and reported similar rearrangements
in the activated lipase structure. In the following years, many biochemical and biophysical
methods had been developed to study this phenomena and they have provided a wealth of
information on the macroscopic properties of lipase activity [38, 45–47].
If we consider the classical Michaelis-Menten kinetics which relies implicitly on the
assumption that enzyme and substrate are in the same phase i.e. both are soluble, one can-
not apply this model directly to the lipase activity at the water-lipid interface. Instead, the
lipase activity at the interface is an example to heterogeneous catalysis which is dependent
on many factors such as interfacial organization, steric conditions of the lipid interface
and lipase structure and the physical interaction between the reactant molecules. In prin-
ciple, the chemical interactions of the lipase and the substrate is coupled with many other
physical processes such as adsorption, desorption and diffusion of the reactants and prod-
ucts [47]. Thus, the reaction rates may be affected by one or any combination of such
physical properties. To date, two mathematical schemes are proposed for the lipase ki-
netics at the interface (Figure 1.5). According to the simplest model proposed by Verger
et al. (1976), soluble lipase (E) is adsorbed on the insoluble substrate interface in a re-
versible manner and fixed at the interface [45]. This adsorption leads to a more favorable
energy state for enzyme (E*) and after this, the kinetics fits into simple Michaelis-Menten
scheme. The enzyme-substrate (E*S) complex is then formed and followed by the forma-
tion of products and their instantaneous solubilization at the interface or in aqueous media.
According to the second model proposed by Martinelle and Hult [48], the lipase exists
in two conformations i.e. open and closed in solution. These two states are in equilibrium
favoring the closed form in solution and when an interface is encountered the equilibrium
changes towards the open form via the adsorption of the lipase to the interface which is
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Figure 1.5:
Models for Interfacial Kinetics. (Model 1) Enzyme stays in the interface during catalysis
or (Model 2) returns to bulk water by dissociating from the interface after product
formation. The dashed line is for two dimensional representation of the interface. For
both models, the products are released to bulk water or stays in the interface with respect
to their physical properties. This scheme is adapted from ref. [50].
stabilized by the hydrophobic environment of the interface.
Understanding the kinetics of TAG hydrolysis by lipases is essential for rational design
purposes to modify catalytic characteristics. However, it may be experimentally labor-
intensive since hydrolysis of water insoluble TAGs takes place at the water-lipid inter-
face and these reactions follow interfacial kinetics rather than simple Michealis-Menten
model [45, 49]. According to the proposed models (Figure 1.5), the lipase is activated by
adsorption to the substrate interface which is composed of several TAG molecules [50].
Then a single TAG binds to the catalytic cleft to form enzyme-substrate (ES) complex of
hydrolysis and this binding is critical for assessing catalytic preference (ΔG‡T ) of lipase ac-
tion at the interface [50]. Unfortunately experimental quantification of single TAG binding
is quite labor-intensive due to the physical properties of lipid substrate [32, 50].
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1.7 Lipases in Industry
Today we know that enzymes are completely biodegradable and renewable as they are
typically produced by fermentation from bio-based materials [51]. Additionally, recent
advancements in the production processes in the last decade show that it is possible to
obtain enzyme concentrates at relatively low costs [52] and these efforts have opened new
doors for enzyme to be applied in bulk industrial process.
Naturally occurring fats and oils are the preferred substrates of lipases yet they can
still catalyze hydrolysis or production of wide range esters [53–56]. Owing to their wide
spectrum of substrates, they are one of the largest class of biocatalysts since two of the
dominating areas of enzyme market -with respect to volume and value of the enzyme-,
food processing (40-45%) and detergent industry (35-40%) are mainly the performance of
lipases [55]. Additionally, novel biotechnological applications has been established using
lipases for synthesis of biodiesel, polymers, drug intermediates, agrochemicals, amino acid
derivatives and flavor compounds [55, 57], as well as in biosensors and bioremediation
processes [58–60]. Table 1.1 explains the most promising lipase applications in various
industrial sectors.
Lipases can catalyze reaction in aqueous and also in organic media. This has made
them particularly attractive for solving challenging synthesis of organic reactions for the
last decade [61, 62]. They have a widespread use in industry (Table 1.1) consequent to
their commercially important reactions/products and this makes them particularly attrac-
tive for protein engineering applications. Because of their extracellular nature, microbial
lipases are easy to produce at large quantities and to isolate. Particularly, microbial lipases
are the preferred source for many industrial applications. The major reasons for the high
industrial potential of microbial lipases include, (i) they are relatively more stable in or-
ganic solvents, at high temperatures and ionic strengths, (ii) they do not require cofactors
(iii) they have a broad substrate selectivity and high enantioselectivity [59]. The interest
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in microbial lipases is reflected by an large number of articles, reviews and monographs
that studied in the molecular biology, biochemical properties and structure of lipases along
with their biotechnological applications [14,18,48,50,63–73]. Examples of such commer-
cially microbial lipases are listed in Table 1.2. Lipases are used in many industrial sectors
that as in production of cheese flavor as in food industry, of detergents as in oleochemistry
and synthesis of various esters as in organic synthesis. The lipase from Penicillium roque-
fortti which has high activity towards tributyrin, the most abundant fat in milk, is used for
production of the flavor in the Roquefort cheese [74].
Apart from the listed examples in Table 1.2, many other known applications of lipases
include removal of the pitch in pulp industry. Pitch is defined as the hydrophobic com-
ponent of wood and must be removed before processing. Enzymatic removal of pitch is
performed via C. rugosa lipase at low costs [75–77]. Textile industry also uses lipases
to bypass the process called ”stoning”, particularly for denim production [78]. The advan-
tages of this enzymatic bypass are numerous including reduced exposure to toxic chemicals
used in chemical process which requires asbestos. Lipases are also used in pharmaceutical
industry due to their ability to synthesize of enantio-pure drugs [79–82]. Examples to this
kind of drugs include Ibuprofen for pain, Taxol for cancer and Diltiazem for high blood
pressure medications. Enantioselective production of drugs by lipases reduces costs and
drug toxicity in pharmaceutical industry.
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1.8 Why Engineer Lipases?
Enzyme catalysis inevitably obeys the thermodynamic rules set for chemical catalysis but
what makes enzymes special is basically their efficiency and selectivity. Using enzymes
as catalysts, the synthesis of specific products is possible due to the selective nature of
enzyme reactions. Selectivity of industrial production greatly reduces waste and energy
consumption, resulting in a much greener manufacture. In this sense, enzyme catalysis
is superior to chemical catalysis and as a consequence enzymes are important for many
industrial applications.
With numerous applications in range of fields (Table 1.1) in bulk industrial processes
(Table 1.2), lipases can be engineered to produce new enzymes with altered substrate selec-
tivities and improved stabilities. Such lipase variants may substantially improve efficiency
of the industrial biocatalysis. Hence, lipases are one of the most popular class of enzymes
that is considered in protein engineering studies [92]. Still, the use of lipases in industrial
processes has some limitations. For instance, harsh conditions faced in industrial processes
can be detrimental to the protein nature of lipases. To overcome this particular limitation,
thermostable lipases are current interest of lipase research [92, 93].
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2 PROTEIN ENGINEERING
2.1 Background
Protein engineering is the research field that concerns design of new proteins and enzymes
with improved properties and has a unique place for today’s science and technology. The
engineering approaches may rely on different principles, trading off rational approach us-
ing three-dimensional (3D) models against random approach using directed evolution [94].
Many fundamental questions can be answered via protein engineering such as protein fold-
ing/stability and structure/function complementarity [95–97]. Along with its research and
medical impacts, protein engineering has wide variety of industrial applications. Impor-
tant bioproducts such as vaccines, replacement therapeutics and industrial enzymes are
improved and produced via protein engineering. Essentially, the significant growth -50%
per year- in the U.S. enzyme market between 1992 and 1997 was a result of successful in-
dustrial applications of enzymes such as proteases, lipases, substillins and cellulases [94].
2.2 Setting up Rationale for Engineering
A successful application of protein engineering requires knowledge on the composition and
production of proteins and is usually performed in three steps which are design, mutagene-
sis and production. Before altering the composition of the wild-type enzyme, it is essential
to have a well-defined rationale for the design. In literature, there are numerous examples
utilizing wide range of methods for enzyme engineering purposes however, the engineer-
ing rationale may be based either on the selection of the improved enzymes from pools
of randomly generated variants or on the rational design of new enzymes with improved
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properties [94]. Table 2.1 lists widely used tools for random and rational approaches. The
random approach is generally accompanied by randommutagenesis which is the laboratory
practice of evolution for a DNA fragments and thus often referred as directed evolution.
The method is based upon generation of a library of mutants and its success is principally
dependent on the screening method. As explained by F.H. Arnold, a convenient and rapid
screening strategy for variations is required for random approach i.e. ”you get what you
screen for” [98]. In random approaches, the design and mutagenesis are performed at the
same time and rely on directed evolution which is multiple random mutations introduced
successively into a DNA piece [99], or domain-swapping which is shuffling of multiple
genes [100], or circular permutation which is shuffling of protein termini (2.1) [101].
In rational approach, design and mutagenesis steps are separate. In the design, the
rationale is established mostly via computational analysis of three-dimensional structures
i.e. molecular docking and molecular dynamics approaches. The mutagenesis approaches
in rational design is usually site-directed. The selected sites may be substituted with other
amino acids (site-directed mutagenesis) [102] or saturated with the rest of other 19 amino
acids (site-saturation mutagenesis) [103] The rational approach is based on an educated
guess made by utilizing high resolution information on the enzyme of interest [104].
Choosing between random and rational approaches rely on the amount of the starting
information [98]. Random design approaches utilizing evolutionmechanism are applicable
to cases where only little information, i.e. primary sequence is known. If the resolution of
the starting information is high, for example the crystal structure is available, the popular
choice is rational design. The outcomes of the both approaches also differ such that it
is possible to comment on the structure and function relation of the enzymes in rational
design whereas the output is dependent on the screening in random design.
After the design step i.e. selecting critical regions in the enzyme in a random or rational
approach, the straightforward step, mutagenesis is followed for both approaches. The final
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Table 2.1: Protein Engineering Approaches.
Random Rational
Design
Directed evolution 3D models
Domain swapping Molecular docking
Circular permutation Molecular dynamics
Mutagenesis Random Site-directedGene-shuffling Site-saturation
Production Heterologous protein expressionPurification
step is the production of improved enzymes and their relevant characterizations to confirm
improvements. The production stages of both random and rational approaches employ
similar methods which are heterologous expression and/or purification of the recombinant
protein.
2.3 Rational Approach
In rational approach, the first step; design employs mostly computational methods for pre-
diction of the regulatory regions in enzymes, which may be important for the stability,
function, selectivity of enzymes. After design, site-directed mutagenesis and heterelogous
protein expression techniques are carried out to obtain the enzyme analogues. Next, in
this chapter, a methodological overview for the steps of the rational approach are given as
design (subsection 2.3.1), mutagenesis (2.3.2), production (2.3.3).
2.3.1 Design
In rational approach, design of novel enzymes is the first step which involves selection of
critical sites responsible for a given character of the enzyme. The success of design is lim-
ited to the resolution of information on the enzyme of interest. This approach works best
if the 3D structure of protein or enzyme is available. The structures in which the enzyme
is captured during an act, i.e. bound to its substrate analog, is particularly beneficial for
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predicting critical regions for enzyme function. Molecular docking approaches may assist
in the prediction of such regions in the enzyme surface that rules molecular recognition
i.e. substrate/inhibitor binding. In addition, significant progress in molecular dynamics
approaches enables us to see 3D models for enzyme action. Thereof such computational
approaches are significant tools for enzyme engineers during design. Design is an impor-
tant test of our understanding of the enzyme structure and function. Usually, in the design
procedure, there is an obvious logic: choosing sites are close to the active site, which fit
with the proposed reaction mechanism, sites in the binding pocket for the substrate, or sites
that make important structural contributions to the enzyme for example stability. To select
such sites, one need to examine the enzyme structure thoroughly. Thus, the availability of
the 3D structure of the enzyme is essential in this approach. Currently, the Brookhaven
Protein Data Bank [105] is built with great deal of structural information on diverse pro-
teins including enzymes1. After determination of the 3D structures, computer assisted ap-
proaches are now an indispensable tool for protein studies since it provides novel insights
to complex systems which may be inaccessible to experimentation.
Technically speaking, proteins are sets of Cartesian coordinates varying at positions
(x,y,z) of N, O, C, S and H atoms of hundreds of amino acids that constitute them. Even
if a small portion of protein structure is considered for analysis, computers are the only
convenient tool to deal with such large number of datasets. Computational methods provide
powerful service for understanding the atomistic details of biological phenomena ruled by
proteins and their partners. Computers can also be used as a convenient viewing interface
examining the very details of protein structure. The advances in the computer assisted
methods have a direct impact on the structural analysis of enzymes [106–108]. Molecular
docking approaches could be used to model enzyme-substrate interactions whereas other
methods developed for estimating the free energy changes from multiple steered molecular
1Enzymes compose 20% of all PDB entries according to PDB statistics released in 2012.
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dynamics trajectories [109]. Following subsections, (2.3.1, 2.3.1, 2.3.1) gives an overview
of three of the computational methods used in this thesis. Few methods related to design
are explained in the subsections.
Molecular Docking
In molecular modeling, docking is a way of predicting the orientation of a molecule with
respect to a second when they are bound to form a complex. Using scoring functions,
knowledge of the preferred orientation can be used to determine the strength of binding
i.e. affinity between two molecules. Docking plays an important role in the rational design
of inhibitors for receptors as well as substrates for enzymes [110, 111]. Considering the
biological and pharmaceutical significance of molecular docking, considerable efforts have
been dedicated to improve the docking methods. Two main categories for molecular dock-
ing can be listed as: (i) rigid-flexible docking which allows only ligand (substrate or drug
molecule) to change its orientation (depending on its torsional degree of freedom) during
docking calculation and (ii) flexible-flexible docking which also allows macromolecule
(protein or enzyme) to change its orientation for example around the active site.
A number of algorithms are developed for molecular docking purposes, these include
AutoDock [112], FLEX [113] for small ligands and HADDOCK [114] particularly de-
veloped for protein-protein docking. AutoDock, the most cited small molecule docking
algorithm, predicts dominant intermolecular complexes of proteins and ligands of known
3D structure. Currently the software is distributed in two versions AutoDock 4 [112] and
AutoDock Vina [115]. AutoDock Vina is better suited to large ligand docking with in-
creased accuracies at improved speeds compared to AutoDock 4. In this method, the
ligand-protein interactions by means of electrostatic interactions, hydrogen bonding and
desolvation energies are calculated over a pre-defined grid which includes the binding re-
gion for ligand [116]. The Genetic algorithm is used to search for the global minimum of
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the bound complex.
Molecular docking approaches are used to estimate the 3D model for the complex
molecules in biological systems and spotting such complexes holds importance by means
of their biological relevancy as displayed previously in examples [117–119].
Molecular Dynamics
Molecular Dynamics (MD) is a powerful computational method that describes the equi-
librium and dynamics of a biological system via generating configurations of that system
by integration of classical mechanics to calculate the time dependence of the system. MD
generates information at the microscopic level which includes atomic coordinates and ve-
locities and the simulations are used to understand the dynamics of the biological system.
In this respect, MD simulations can be used to resolve structure-function relationship of
proteins.
MD technique is widely used in the context of molecular biology. Protein dynamics is
first introduced by McCammon et. al. in 1977 through an analysis using bovine pancreatic
trypsin inhibitor [120]. NowMD has widespread use for several purposes including refine-
ment of X-ray and NMR structures, searching for new conformations and calculations of
binding energy.
Building and/or manipulating a protein structure in the computer requires knowledge of
the bond, angle, torsion and atomic radii of the protein structure. MD simulations are per-
formed with a set of force fields that corresponds to the potential energy of the static protein
structure. The potential energy of a rigid protein was previously described by a number of
force fields such as ECEPP [121], Hagler’s [122, 123], Herman’s [124], Allinger’s [125],
MM2 and CHARMM [126], AMBER [127], GROMOS [128] force fields. These force
fields are employed to built a wire model for a protein and the potential energy of the
protein molecule is obtained by a number formulations that computes bonded i.e. rota-
22
Figure 2.1:
Energy terms for Simple Molecular Mechanics. Non-bonded atoms (greater than two
bonds apart) interact through van der Waals attraction, steric repulsion, and electrostatic
attraction/repulsion. Bonded interactions in a simple mechanical force field include
stretching, bending and torsions.
tions and torsions, and non-bonded i.e. van der Waals and electrostatic potentials (Figure
2.1). For the time dependent change in the bond lengths, bond angles and torsions, also
the non-bonding van der Waals and elecrostatic interactions between atoms, force fields, a
collection of formulations are used.
At any temperature above absolute zero, the total energy of a protein molecule is com-
posed of potential energy and kinetic energy of the thermal motions of the atoms. This
motion can be generated via computers by calculating the derivatives of the potential ener-
gies i.e. velocities, accelerations and forces at time t+Δt by integration as in classical me-
chanics. Smooth motion trajectories are obtained for very short integration steps, mostly
on the order of femtoseconds (s−15) and a molecular dynamics trajectory is the collection
of the successive frames of the atomic positions and velocities. In molecular dynamics,
these empirical force fields can also be coupled with a random drag force which may be
user-defined to study unfolding and binding of ligands. Development of force fields as
mathematical expressions for these features which is the field of molecular mechanics, re-
sult in many software packages for MD simulations of biomolecules [129]. NAMD, the
most widely used software package, is used in this thesis [130].
In MD simulations, the molecules are surrounded by boundaries which act as symmetry
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operators to generate periodic boundary conditions. These periodic boundary conditions
enables the simulation to be completed using a relatively small number of particles such
that these particles experience forces as they are in bulk solvent.
MD has broadened our understanding of motions of biological molecules which are
often inaccessible for experimentation. It permits the study of complex and dynamic pro-
cesses in biological systems such as folding, stability, conformational changes and trans-
port mechanisms. Although, longer simulation times and larger systems requires more
computational power, speed of computers and parallel computing algorithms are getting to
more advanced levels improving the accuracies of computer modeling techniques.
Nonequilibrium Methods for Free Energy Calculations
Most biological complexes shuttle between two equilibrium states at time scales that are
beyond the reach of current MD simulations, their equilibrium dynamics cannot be repli-
cated in a straightforward manner. Nevertheless one can overcome this problem by using
biasing or adaptive methods. Here, the steered molecular dynamics (SMD) together with
Jarzynskis equality [109] which is a popular non-equilibrium method is explained [131].
In 1997, Jarzynski has postulated an equality between nonequilibrium work functions
and equilibrium free energy differences in a microscopic system, which provides a power-
ful tool for the determination of equilibrium free energy changes in the context of steered
molecular dynamics simulations. This equality has so far intensely applied for several
objectives including ligand binding to protein [109, 132–141].
The SMDmethod is based on guiding the system from one equilibrium state to another
by a drag force [142,143] which can be seen as an in-silico counterpart of single-molecule
experiments that utilize atomic force microscopy or laser tweezers [144, 145]. According
to Jarzynskis equality, the Boltzmann average of the work functions obtained from the
SMD simulations provides an estimate of the potential of mean force of the ligand along
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the reaction coordinate, which approaches the true value when the system is sampled suffi-
ciently [109]. During SMD simulation, one part of the system, i.e. ligand, is coupled with
a harmonic oscillator. The spring is pulled to build up a certain tension on the ligand. The
movement of this spring builds up a certain tension which results in a molecular transition
i.e. unbinding and unfolding [146]. Because SMD is a path-dependent method, it can also
be used in searching for a ligands pathways [136, 147]. Furthermore, the trajectory data
obtained from SMD simulations provide a wealth of information which can be utilized, for
example, in finding the critical enzyme residues that strongly interact with a ligand along
its path. Such information would be very useful in rational design of enzyme analogues
with improved selectivity properties for a particular ligand.
While SMD simulations are less laborious and easier to implement compared to other
path-dependent approaches such as umbrella sampling MD simulations, they require rela-
tively more computing time to obtain the same level of accuracy [148, 149]. Nevertheless,
this approach may be applied for the cases where the comparison of two systems with ei-
ther different ligands or different macromolecules is considered. Additionally, inaccuracies
in force fields such as missing polarization interaction [150,151] are expected to affect the
absolute binding free energies of ligands but not their relative values. The nonequilibrium
methods like Jarzynskis equality are obviously useful for the cases where nonequilibrium
conditions are dominating and cannot be easily avoided. Following the Jarzynski’s equal-
ity, other approaches are also developed for similar purposes [152].
2.3.2 Mutagenesis
Mutagenesis is one of the most widely used DNA manipulation techniques. Via mutage-
nesis, one can investigate the impact of sequence alterations in the DNA and also in the
downstream process of DNA expression i.e. mRNA, protein. Today, it is possible to se-
lect from a wide range of mutagenesis approaches that include chemical, oligonucleotide-,
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polymerase chain reaction (PCR)-based and cassette mutagenesis [94]. Among these mu-
tagenesis ways, site-directed mutagenesis which is widely used for protein engineering
purposes is focused here.
Site-directed mutagenesis is an in-vitro method based on PCR. It uses PCR, more
specifically, overlap extension PCR (OE-PCR) to generate specific mutations at predeter-
mined locations of a DNA piece [102]. Figure 2.2 illustrates the principle of site-directed
mutagenesis via OE-PCR. The mutant sequences are carried in the primers which are used
for amplification of mutant DNA. The second round is another PCR uses first reaction prod-
ucts as primers and template. For about 10-20 steps -depending on the length of the overlap
region- the second PCR does not require primers but after some point, the efficiency of am-
plification can be enhanced using gene-specific primers annealing at the 5’ and 3’ of DNA
piece. Today, there are also other kit based approaches which are relatively easier and faster
because these kit-based approaches bypass cloning steps [153]. Lastly, artificial gene syn-
thesis is now relatively cheaper as it can be provided by numerous companies worldwide.
Gene synthesis may save time and money compared to mutagenesis procedures. But for a
large number of mutants, these kit based approaches and gene-synthesis may be costly.
2.3.3 Production
After mutagenesis, next aim is to produce recombinant proteins (wild-type and/or mu-
tants). Heterologous protein expression is used for this purpose owing to the availability of
various expression systems such as Escherichia coli, Saccharomyces cerevisiae and Pichia
pastoris. E. coli will be given special emphasis here and in the thesis.
The host, E. coli because of being a prokaryotic species has resulted in loss of about
70% of eukaryotic protein expression but this host is still the first choice in most of the
protein engineering approaches [94]. Since, E. coli is actually the organism on which the
recombinant DNA technology is founded and there are lots information on the mechanism
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Figure 2.2:
Principle of OE-PCR. A graphical illustration of OE-PCR method and the corresponding
templates and primers for sequential PCRs are shown. The legend is given at the bottom
of the figure.
and machinery of the E. coli expression system. In this regard, E. coli may be an ideal
first choice for an expression study. Moreover, co-expression studies showed that E. coli
can express more than one protein at the same time [154]. The choice of expression host
is also dependent on the enzyme of interest. For eukaryotic proteins, mostly yeast sys-
tems are preferred due to their ability to perform post-translational modifications on the
recombinant proteins such as phosphorylation and glycosylation. Other than this, there
are several factors need to be looked in expression study such that the choice of promoter
and strain may directly affect the efficiency of expression. Moreover, in order to obtain
soluble forms of the recombinant enzyme product, the gene sequence for it may be fused
with another gene piece which produces soluble proteins such as glutathione-S-transferase
and maltose binding protein.
The production may be scaled up according to the needs: a cellular protein can be
expressed to study its function in cell biology, bench-scale production of protein can be
achieved for characterization studies or the production can be scaled up to fermentation for
industrial processes.
27
After design and mutagenesis, last step is to obtain the recombinant products which
is followed by the characterization of the mutations. A range of methods are available to
obtain information from the macroscopic level i.e. protein size, molecular mass, enzyme
activity.
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3 THESIS APPROACH
3.1 Purpose
Schmit-Dannert et al. (1997) investigated two different lipases originating from the bac-
teria, Bacillus thermocatenulatus (BTL1 and BTL2) and they showed that these lipases
have distinct features from each other [155]. BTL2 stood out with its higher activity and
stability compared to BTL1 and other known lipases. BTL2 is of particular interest for
this thesis. Here we report the results of the two case studies on the protein engineering of
BTL2. Chapter 5 aims for the rational design of BTL2 to increase its selectivity towards
C4 TAG and Chapter ?? aims for the investigation of the impact of two tryptophans in the
lid region of BTL2 in terms of activity, thermostability and aggregation. For both chapters,
computational methods are implemented using two atomistic models of BTL2 (PDBID:
2W22 [33] and 1KU0 [156]. The former is used in Chapter 5 and the latter is in Chapter
?? (Figure 3.1).
3.2 Thesis Approach
Lipases, an enzyme class, is explained in the context of their reactions, specificities, struc-
tures and industrial importance in the first chapter. An overview of enzyme-engineering
is given in the second chapter. Here, in this chapter, thesis approach and thesis aims are
explained. The following chapters are related to two protein engineering studies concern-
ing the rational design of BTL2 to enhance the catalytic preference and the semi-rational
design to investigate the function of lid tryptophans in BTL2. Chapter 5 aiming to increase
catalytic preference of tributyrin (C4) hydrolysis of BTL2 involves molecular docking ap-
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Figure 3.1: Thesis Methodologies
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proach to determine the bound configuration of two different TAG molecules at length of
C4 and C8 to the catalytic cleft of BTL2 and molecular dynamics (MD) of these com-
plexes. Following this, steered molecular dynamics (SMD) is performed to model the
dissociation of the bound ligands from the catalytic cleft (Figure 3.1). Upon identifica-
tion of ligands’ path, selected residues which are confined to the catalytic cleft are tested
in-silico using the same SMD approach and in-vivo using the molecular biology methods
for cloning, site-directed mutagenesis and heterelogous protein expression (Figure 3.1)to
modify the catalytic efficiency of lipase. The chain-length selectivity is explained in terms
of the change activation barrier of mutants with respect to TAG chain-length to finalize
the rational design. Chapter ?? is related to molecular investigation of the lid tryptophans
in BTL2. The lid region in lipases are rich in aromatic residues to mediate the hydropho-
bic interactions with the environment. Thermophilic enzymes like BTL2 stay stable at high
temperatures by intra-molecular hydrophobic interactions [157]. BTL2 which is originated
from a thermophilic microogranism could be used to understand the basis of the thermosta-
bility provided by the hydrophobic interactions. These interactions might be critical to the
activity, stability and aggregation tendency of lipases [158,159]. BTL2 has a large portion
of hydrophobic residues, especially it contains two tryptophans (W212, W235) in the lid
domain. Chapter ?? investigates the effects of these tryptophans on the thermostability
and aggregation of BTL2 using similar protein engineering tools (Figure 3.1). For both
chapters, computational methods are implemented using two atomistic models of BTL2
(PDBID: 2W22 and 1KU0). The former is used in Chapter 4 and the latter is in Chapter 5
(Figure 3.1).
3.3 Bacillus thermocatenulatus lipase
Phylogenetic, biochemical and structural information on BTL2 is collected from the rele-
vant literature and given next. In addition, experimental studies are performed with wild-
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type BTL2 ahead of protein engineering to find out the optimum expression and purifica-
tion system.
3.3.1 Lipase Family 1.5
According to the classification of bacterial lipases [160], eight lipase families are identi-
fied with respect to their peptapeptide motif containing catalytic serine. Five of the six
subfamilies found in Family 1 has G-X-S-X-G pentamer while members of Lipase 1.5 has
conserved the A-X-S-X-G motif. Although some features of this subfamily lipases are
divergent from other subfamilies in Family 1, the members of Family 1.5 have significant
sequence similarity and Figure 3.2 shows the multiple alignment of previously identified
lipases from Family 1.5. With a high sequence homology, these lipases also share com-
mon biochemical and structural features. As these lipases are mostly originated from a
thermoalkalophilic species, they work best at high pH and high temperatures [161, 162]
Moreover, this family lipases are larger lipases (more than 40 kDa) [160] compared to other
subfamilies because they possess an extra domain for zinc coordination which accounts for
increased thermostability and also not found in other lipase families [156]. Owing to some
unique and conserved characteristics, members of family 1.5 have been a particular interest
of enzyme engineers [163, 164].
3.3.2 Heterologous Expression Trials
Before engineering of this lipase, the native BTL2 is expressed in two heterologous hosts:
E. coli and P. pastoris. Among these two hosts, E. coli is preferred for BTL2 expression
-although both of the expressions are successful- since E. coli system is the most conve-
nient way of heterologous expression. In these E. coli expressions, fusion tags are used
(Figure 3.3). These include poly histidine (six-His), glutathione-S-transferase (GST) and
maltose binding protein (MBP). Such tags are important for the solubility of recombinant
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Figure 3.2:
Multiple Sequence Alignment of Lipase 1.5 Family. The penta peptide motif that holds
catalytic serine is shown in lines and catalytic triad are also shown with dots. The
secondary features are also shown on top of the alignment. The sequences of two Bacillus
stearothermophilus lipases (PDB ID: 1JI3, 1KU0), Bacillus thermocatenulatus lipase
(PDB ID: 2W22) and Geobacillus species SBS-4S lipase (3AUK) are used in the
alignment.
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Figure 3.3:
E. coli Expression of BTL2 in Native and Fusion Forms. 12.5% SDS-PAGE analyses are
shown for (A) soluble E. coli lysate and (B) native BTL2. (A) Lane 1 is the molecular
weight marker (Fermentas SM0671, see Appendix A.1) and lane 3, lane 5 and lane 6
corresponds to BTL2 expression in fusion forms of respective tags: GST, MBP and poly
histidine. The expected positions for the fusion proteins are marked with red arrows
(BTL2: 43 kDa, GST: 30 kDa, MBP: 50 kDa poly histidine: 1 kDa). (B) BTL2-GST
fusion is cleaved by TEV protease whose recognition site is located in the C-termini of
GST. Lane 1 is same marker. The amount of the protease is increased gradually from lane
2 to 8. The corresponding molecular size for BTL2-GST (73 kDa), TEV (26 kDa), GST
(30 kDa) and native BTL2 (43 kDa) is marked. Protease cleavage is performed in 100
mM Tris-EDTA buffer at pH 8.0 with 1 μM DTT.
protein and may be increase the efficiency of expression [165–167]. These tags also ease
the purification steps which is essential for protein engineering studies [168]. But in a typ-
ical protein engineering study, it is important obtain native lipase rather than its soluble but
fusion forms. Native BTL2 is shown in Figure 3.3. It is obtained after proteolytic cleavage
of the GST tag by Tobacco Etch Virus (TEV) protease as described in ref. [169]. This
native enzyme is compared with its smallest fusion form (BTL2-his) in a set of experiment
which are analyzing lipase activity and thermostability. These tested biochemical features
do not differ in between native and poly histidine fused BTL2. Considering affinity purifi-
cation of tagged proteins, lipase expressions are conducted via poly histidine fusion in E.
coli throughout this thesis.
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3.3.3 Biochemistry
An 1167-bp fragment codes for the mature thermoalkalophilic lipase. It has composed
of 389 residues and a predicted molecular weight of 43 kDa. Lipase was found to be
stable at pH range of 9-10 and temperature range of 60-70oC [155]. Optimal working
pH range for BTL2 is 8-9 and temperature is 60oC [170] BTL2 preferentially catalyzes
sn-1/3 acyl chain in triglycerides similar to other microbial lipases. BTL2 has a narrow
chain-length selectivity profile that it exhibits activity towards short and medium chains
(C4-C8) with a distinct preference to tributyrin (C4) but it has low activity towards long
chains of triglycerides (C10 and longer) [162]. BTL2 is also stable in organic solvents
and detergents [162]. In a set of experiments, prior to mutagenesis, we have also analyzed
some of the biochemical properties of native lipase tagged with poly histidine. Effects of
pH on lipase activity is given in Figure 3.4 A. The pH stability analysis is performed at the
pH range of 4-10 is provided in a tri-buffer system [171] which allowed us to eliminate the
buffer composition effect on stability of lipase and BTL2-his is found to be stable at the
pH range of 7-9 in our experiments which is in agreement with the native BTL2. (Figure
3.4 A) The effects of 11 different metals (Al, Ca, Cd, Cu, Fe, K, Li, Mg, Mn, Na, and Zn)
in form of chloride salts are investigated in a concentration gradient. (Figure 3.4 B). Ca,
Cd, K, Li, Mg and Na metals do not affect the activity of this lipase in the pure or lysate
form whereas BTL2-his is observed to lose a quarter of its activity even at the lowest metal
supply of 1 mM for Al, Fe, Mn and Zn presence.
3.3.4 Structure
The crystal structure of BTL2 is resolved at 2.5 A˚ [33] This crystallization study attracted
profound attention, due to the fact that there were no open-state structures, meaning the
binding pocket for substrate is available, belonging to lipase family 1.5. Similar to most
microbial lipases, BTL2 is a member of α-β hydrolase fold family [172] The structure has
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Figure 3.4:
Effects of Metal and pH on Activity.(A) Effect of pH on lipase activity. The pH stability
of BTL2 is tested by incubation for 12 hours (patterned bars) and 24 hours (white bars) at
room temperature. Residual enzymatic activity is determined in tri-buffer system [171]
using fluorescent substrates in reaction mixture of 0.1 M Tris pH 7.25. (B) Effects of
metal ions on activity are displayed in bar diagrams using chloride salts of metals: Al+3,
Ca+2, Cd+2, Cu+2, Fe+2, K+, Li+, Mg+2, Mn+2, Na+ and Zn+2 which are supplied at
concentration of 1 mM to expression lysate (white bars) and pure lipases (patterned bars).
Error bars are showing the deviations of the duplicate measurements.
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Figure 3.5:
Crystal structure of BTL2. The crystal structure (PDB ID:2W22) is visualized using
VMD. Central beta-sheets are colored in red and alpha-helices are shown in green
cartoons. The loop regions are transparent grey ribbons.
seven strands of hydrophobic β -sheets packed in central and surrounded by α-helices. Fig-
ure 3.5 illustrates 3D structure of BTL2 and the secondary structural elements constituting
it.
Active Site and Catalytic Cleft
Positions of two detergent molecules (Triton-X-100) in crystal structure aided in identifi-
cation of active site cleft. The cleft has dimensions of 14 A˚ in-depth, 18x25 A˚2 in-area and
is ovoid in shape [33]. The walls of the cleft are lined with hydrophobic residues (A241,
I320, I363, L171, L184, L189, L209, L245, L360, L57, M174, F17, F182, F291, P165,
Y30, V172, V175, V188, V234, V295, V321 and V365). These residues play role in sta-
bilization of the acyl chains of TAGs. Moreover the aromatic side chain of the residue F17
cuts the cleft in two. Four binding pockets have been identified in the cleft; an oxyanion
hole and three pockets for the different branches of the TAG substrate. The positions of
the oxyanion hole and of the three pockets that accommodate the sn-1, sn-2 and sn-3 fatty
acid chains is also identified in 2W22. S114 is the catalytic residue whereas the other
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two residues (H359, D318) that have role in stabilization of the catalytic attacks made by
serine. Serine is found in the motif of A-X-S-X-G, abundant in thermoalkalophilic lipases.
Lid Domain
As with most lipases, another structural element, highly mobile, is also located at the
entrance of the active cleft. This element is referred as lid. Two short α-helices (α6 and
α7), composed of residues from comprising the lid structure, are found to be linked to core
with high flexibility. The lid is opened due to specific interactions of the substrate with the
lid helices, a process called interfacial activation. Compared to the closed-form, the C-
termini of both helices move about 20 A˚ away from the entrance of the active cleft [156].
Two structures corresponding to BTL2 is used in Figure 3.6 to see the differences in the
open-lid (PDB ID: 2W22) with respect to its closed form (PDB ID: 1KU0). In the closed
form, two helices compose the lid structure. The second helix (Figure 3.6) moves laterally
away from the cleft opening. This movement is simply rolling of the second α-helix to
move its center of mass about 20 A˚. Although this helix does not show any change in its
structure and composition, its movement causes disruption of the first helix in lid. The
first helix in the closed conformation is broken into two smaller α-helices which make the
catalytic serine available for substrates (Figure 3.6). Moreover, the last α-helix in the lid
changes its conformation to a 310 helix which further contributes to the enlargement of the
cleft opening.
Zinc Domain
Extra domain for Zn-coordination, common among lipase family 1.5, is also found in the
structure [156]. The open conformation and previously identified closed-conformation of
Bacillus stearothermophilus lipase (Figure 3.2 do not show significant distinctions in their
zinc domains [28]. The extra domain is assumed to account for the increased thermosta-
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Figure 3.6:
Lid Conformations. Multiple alignment of lid region and secondary structure of lid in the
open and closed conformation. Top sequence and secondary structure of the lid is for
closed conformation (1KU0) and bottom is for the open state (2W22). The changes in the
secondary structure of the lid domain is also given in top view representation of lid
helices (green: open-conformation, red: closed, blue sphere: Cα of catalytic serine). The
same legend in Figure 3.2 applies here for the secondary structure representations given
on top and bottom of the sequence.
bility in this family of lipases [156].
3.3.5 Potential Applications of BTL2
With respect to the chain length selectivity, BTL2 stands out from others as it has the
highest specific activity for the short-chain fatty acid C4 TAG compared to other chain-
lengths [155, 162]. BTL2 is a thermostable lipase belonging to the Lipase Family 1.5 and
shows characteristics of this family [63, 90,160, 164]. Thermostable lipases like BTL2 are
of high importance in industry because of their tolerance to extreme conditions faced in
industrial processes [10,18,173–175]. In this sense, BTL2 could be an effective alternative
to its biocatalyst counterparts in industry [176–182]. Moreover, members of the Lipase
Family 1.5 have 95% sequence identity, and hence any finding on BTL2 is likely to be
valid for the whole family [160].
Considering previously mentioned lipase applications in various industrial sectors (Ta-
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ble 1.1 and 1.2), the native BTL2 is appropriate both for enrichment of long-chain triglyc-
erides and production of short chain fatty acids as it has highest specific activity toward
tributyrin and may be used in dairy industry in preparation of cheese flavors as well as
milk fat production. Moreover, BTL2 is shown to act as a biocatalyst for these hydrolytic
reactions with different chiral substrates [163, 183], which makes BTL2 and its catalytic
properties important for industry. The native properties found in BTL2 may be improved
through protein engineering to be applied in such sectors. Moreover, since BTL2 is ther-
mostable lipase, it would make the industrial reaction more efficient when compared to its
mesophilic counterparts [93].
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4 RATIONAL DESIGN OF THE CHAIN
LENGTH SELECTIVITY
4.1 Summary
Rational design for Bacillus thermocatenulatuslipase (BTL2) is performed to lower the
activation barrier for hydrolysis of short chain substrates. In this design, two computa-
tional models for the enzyme substrate complex is used for tributyrin (C4) and tricaprylin
(C8) which are generated through docking and molecular dynamics simulations. These
ES complexes are employed in steered molecular dynamics (SMD) with Jarzynski’s equal-
ity to estimate their relative binding free energies. Potential mutation sites for modifying
the chain-length selectivity of BTL2 are found by inspecting the SMD trajectories and
fine-tuning the volume and hydrophobicity of the cleft. The implementation of the SMD
method allows the appraisal of the binding free energy of the ES complex at the inter-
face, which might be an experimental challenge. In the experimental section, the steady
state specific activities towards C4 and C8 TAGs are determined and combined with the
SMD findings to profile Gibbs energy diagrams for C4 and C8 hydrolysis in BTL2 mu-
tants. Here, the implementation of the computational method not only provides us with
the binding affinity of ES complex, but also enables us to inspect the dynamics of the ES
complex which is useful for rational design purposes. The combined approach described
in this study can be used for other lipases and enzymes to investigate their complex re-
action mechanisms via single molecule models and also, to design enzymes with altered
substrate-selectivity.
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4.2 Methods
4.2.1 Structure Preparation
The crystal structure captured in the open conformation (PDBID: 2W22) is used for mod-
eling Bacillus thermocatenulatus lipase and its TAG substrates. TAG molecules with a
glycerol as the head group tailed with three chains at lengths of tributyrin (C4), tricaprylin
(C8) or trilaurate (C12) are used as the ligands. Autopsf plugin in VMD is used to gen-
erate structure files using the CHARMM topology parameters of three ligands (given in
Appendix A.3. Mutator plugin is used for in-silicomutagenesis of lipase structures.
4.2.2 Docking
TAG molecules at the chain-lengths of C4, C8 and C12 are recruited to automated docking
suite [115] as ligands. 2W22, the open-conformation, is used as the receptor molecule by
eliminating two Triton-X 100 molecules and other ligands in the structure. The ligand is
left flexible whereas receptor is rigid during docking. C4 and C8 ligands possess a torsion
tree of 14 and 26 rotatable bonds, respectively (Figure 4.1). A total of 10 local searches
via Lamarckian Genetic Algorithm (GA) are carried out for the global minimum of the
bound complex. Each search consists of a population of 200 members. The search space
is contained the catalytic cleft and it is further inspected to include whole opening of this
cleft. The exhaustiveness level is set to 128 for Vina calculations in the energy range
of 10 kcal/mol. The complex configurations are obtained after the analyses of the docking
outcomes by means of poses and scores of poses. The final configurations of 2W22-C4 and
2W22-C8 complexes are decided according to two critical parameters such as the catalytic
distance and orientation. Unless the complex configurations secure side-chain orientations
and distances of the side chain hydroxyl of S114 and the ester oxygen of the bond joining
glycerol to fatty acid of TAG substrate is replicated as in the crystal [33], they are ignored.
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Figure 4.1:
Torsion Tree of C4 and C8 Ligands (Green: rotatable, red: non-rotatable).
The complex molecules having catalytic distance lower than 5 are subsequently simulated
in MD. Due to relatively larger size of C12 ligand, docking procedures used for C4 and
C8 ligands are not particularly successful for C12 ligand. To replicate crystal parameters
in 2W22-C12 complex as well, the coordinates of 2W22-C8 complex are used to generate
structure files by exchanging the CHARMM topology parameters of C8 to C12.
4.2.3 Molecular Dynamics
Thre systems containing 2W22 structure as the receptor and C4, C8 or C12 as the ligand
are generatured to compose of 55,000, 57,000 and 58,000 atoms, resepctively. The com-
plex systems are placed water box with dimensions of 72x83x92, 82x83x97 and 82x85x95
A˚3, respectively. NAMD with the CHARMM22 parameters is used for molecular simula-
tions which are carried out in water box under natural ionic conditions which is 100 mM
NaCl as previously defined for thermoalkalophilic lipases [184]. An NpT ensemble is used
in MD simulations with periodic boundary conditions. The long-range Coulomb interac-
tions are computed using the particle-mesh Ewald algorithm. Pressure and temperature is
kept constant at 1 atm and 300, respectively using the Langevin pressure and temperature
coupling. A time step of 2 fs is used in all MD simulations. Following a 1000 step energy
minimization, all systems are simulated for nanosecond time scales.
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4.2.4 Steered Molecular Dynamics
The starting structure files for SMD simulations are taken from the previous MD simula-
tions. Each starting configuration is equilibrated in the absence of external forces before
the SMDmethod is used to pull the ligand from the receptors cleft. The cleft axis is chosen
as the reaction coordinate which is aligned with the z axis for convenience. Despite the
fact that the cleft is buried 14 A˚ deep into the protein core, a straight path can still be drawn
from the catalytic triad to the cleft opening, which allows use of a unidirectional force in
SMD simulations. The third carbons of all acyl chains in C4 and the seventh carbons of
all acyl chains in C8 are selected as the SMD atoms where the pulling forces are applied.
A harmonic force with a constant k = 20 kcal/mol.A˚−2 is cantilevered to a dummy atom
placed at the center of mass of the three SMD atoms of each ligand, which is distributed
among the three carbon atoms. The ligand is pulled at a constant speed v until it is com-
pletely dissociated from the enzyme. Pulling speeds from 20 to 2.5 A˚/ns are considered,
and the speed of 5 A˚/ns is found to yield optimum results for accuracy vs. computing time.
The total force experienced by the ligand is given by,
F(t) = k[vt− z(t)] (4.1)
where z is the displacement of the dummy atom from the initial time to time t. The
pulling lasted for 6, 7 and 8 for the ligands C4, C8 and C12, respectively. Ten indepen-
dent SMD simulations are performed for each ligand. The work function for each SMD
trajectory is calculated from the line integral of the force in Equation , and the potential
of mean force (PMF) is determined from the individual work functions using Jarzynskis
equality [109],
e
−GS
kBT = 〈e
−W
kBT 〉 (4.2)
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where ΔGS is free energy difference, W is the work function, kB is the Boltzmann
constant, and T is temperature. The same procedure is used in calculation of the PMFs of
ligands bound to the mutant enzymes.
4.2.5 in-silicoMutagenesis
MD and SMD trajectories are used to predict mutations in the catalytic cleft of 2W22.
Eight different mutants are generated using 2W22-C4 and eight for 2W22-C8 complexes.
C12 ligand is not employed in mutant structures. Mutations are chosen so as to increase or
decrease the cleft volume available to the acyl chains of the C8 TAG. In order not to disturb
the binding of C4, only the residues that interact with the 5th and further carbon atoms of
the C8 acyl chains are considered for mutation. For this purpose, pair distances of the C8
ligands 5th carbons with the side chain atoms of the selected lipase residues are measured
in initial SMD runs. The residues that have yielded pair distances less than 10 with the
5th carbon of the C8 ligand are considered in site-directed mutagenesis. Four different
mutants with single amino acid changes (L57F, V175F, I320F and L360F) are considered.
Two residues from the sn-1 pocket (V175 and I320), and one residue from the sn-3 pocket
(F17) are also mutated to alanine to further investigate the effect of volume change in the
binding. The side chains of all of the selected residues point towards the cavity and do not
have any interactions with the protein backbone. The active site residues residing in the
oxyanion hole are excluded in mutagenesis studies to avoid substantial decrease in lipase
activity.
All of the mutants systems are energy minimized in 1000 steps and employed in MD
simulations. To investigate chain-length selectivity, 8 mutants of 2W22-C4 and 2W22-
C8 complexes are simulated for 1 ns in the absence of external forces and the starting
configurations for SMD method are selected from the last 0.1 ns. For the mutant systems,
L57F, V175F, I320F, and L360F, the configurations at the end of 1 ns have resulted in a
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wrong conformation of the C8 ligand (e.g., the catalytic pairings observed in the crystal
structure is lost and the position of C8 is shifted along the z-axis). Therefore restraints
are introduced on the C8 ligand for these mutant systems. The head group carbons of the
ligands are initially restrained with a harmonic force of 10 kcal/mol.A˚−2, which is reduced
to 0 in five equal steps over the course of a 500 ps MD simulations. With this procedure,
complex structures consistent with the crystal structure are obtained. Again each mutant
system is simulated without restraints for 1 ns to provide the initial configurations for the
SMD simulations. 5 pulling events with constant speed of 5 A˚/ns are carried out for each
mutant in SMD and PMF is profiled for each mutant, similarly with Jarzynski’s Equality.
4.2.6 Molecular Cloning
A 1,167-bp DNA fragment corresponding to the Bacillus thermocatenulatus lipase gene
(BTL2) is amplified from the mature lipase clone (pPICZα A-BTL2) DNA using the
primer set containing ligation independent cloning (LIC) sites; (bold) for forward (F
BTL2 LIC: 5- TACTTCCAATCCAATGAA GCGGCATCCCCACGCG -3 and for re-
verse (R BTL2 LIC: 5- TTATCCACTTCCAATGAA AGGCCGCAAACTCGCCAA
-3). PCR conditions are given in Table 4.1. 4 μg of the expression vector, pMCSG7 is
linearized using SspI restriction enzyme (see Appendix A.4for vector maps). Linear vec-
tor and PCR product are electrophoreted at 100 V in 1.2% agarose gels using tris borate
edta (TBE) buffer system for 30 minutes. Both fragments are extracted from agarose gel
and treated with T4 DNA Polymerase. The exonuclease activity of T4 DNA polymerase
is terminated using excess concentration of dGTP for vector and dCTP for PCR product
depending on the given LIC sequences. The reaction is lasted at 20oC for 50 minutes
and heat-inactivated at 70oC for 20 minutes. T4 DNA polymerase treated DNA are sub-
sequently extracted to aqueous phase using phenol/chloroform and precipitated in cold-
ethanol. Vector and PCR product are solubilized in 10 μl of distilled water and annealed
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Table 4.1: PCR Cycle Profile for BTL2 Amplification.
Step oC min Cycle
Initial Denaturation 94 3 1
Denaturation 94 0.5
35Annealing 52 0.5
Extension 72 1
Final Extension 72 7 1
Hold 4
at 23oC for overnight. Chemically competent E. coli XL1-Blue cells are prepared accord-
ing to ref. [185]. All of the reaction mixture is transformed to E. coli XL-blue cells via
chemical transformation [186] Colony PCR reactions are set using BTL2 LIC primer pairs
and given with cycle profile given in Table 4.1 for two selected colonies. All of the am-
plifications are size separated in 1.2% agarose gels using GeneRulerTM 1 kb DNA Ladder
SM0311 (Fermentas, see Appendix A.1 for the marker legends). Plasmid purifications are
performed from two colony-PCR positive clones and purified plasmids are digested with
EcoRI and NdeI to confirm BTL2 gene. The plasmid purifications are done using Qia-
gen Plasmid Purification kit following the manual. The restriction digestion with EcoRI
and NdeI is performed as recommended by the supplier (Fermentas). Plasmids are se-
quenced using T7 Terminator (5- GCTAGTTATTGCTCAGCGG -3) and T7 Promoter (5-
TAATACGACTCACTATAGGG-3) by Molecular Cloning Laboratories (MCLAB).
4.2.7 Site-directed Mutagenesis
7 single mutations and one double mutation are generated using Overlap Extension PCR
(OE-PCR). The mutations and corresponding primers are listed in Table 4.2. For alanine
substiution, GCG triplet, for phenylalanine, TTT is preferred obeying the codon preference
displayed by E. coli [187]. For each mutant, two amplification reactions are set: (i) using
primers: F BTL2 LIC as forward and mutant primers as reverse (ii) mutant primers as
forward and R BTL2 LIC as reverse -a schematic representation for this reaction is given
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in Figure 2.2. These fragments are extracted from 1.2% agarose gel and used to amplify
full-length fragment in OE-PCR. The first 15 cycles in this PCR are performed without
any primers. After 15 cycles, BTL2 LIC primer pairs are added into reaction mixture. The
amplification conditions for sequential PCRs explained here is given in Table 4.3.
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Table 4.3: PCR Cycle Profile for Site-directed Mutagenesis and OE-PCR.
1st Round 2nd Round Cycle
Step oC min oC min
Initial Denaturation 94 3 94 3 1
Denaturation 94 0.5 94 0.5
35Annealing 65 1 53 0.5
Extension 72 1 72 1
Final Extension 72 7 72 7 1
Hold 4 4
The mutant fragments are cloned into pMCSG-7 backbone using same cloning proce-
dure given described for BTL2. The double mutant is amplified after construction of I320F
mutant. The PCR reaction for the double mutant is used I320F clone -sequence confirmed-
as the template and L360F mutant primers given in Table 4.2.
4.2.8 Lipase Expressions
Sequence confirmed clones are transformed to Shuffle E. coli cells via chemical trans-
formation and single colonies are selected for expression studies. Each clone (wild-type,
F17A, V57F, V175F, V175A, I320F, I320A, L360F and I320F/L360F) are plated on LB-
rhodamine plates which are prepared with slight modifications to the ref. [188] to check
the lipase activity. All mutants are also expressed in liquid culture using 1 mM IPTG
(isopropyl-β -D-thiogalactopyranoside) in LB. The expressions are lasted out for six hours
and sampled once at the fourth hour. The cells are harvested by centrifugation (maximum
speed on table top microcentrifuge for 5 min) and lysed using B-PER (Thermoscientific).
B-PER solubilized samples are fractioned by centrifugation (maximum speed on table top
microcentrifuge for 10 min). Lipase activity of soluble fractions is determined using fluo-
rescent substrates, 4MU-C4 and 4MU-C8 in 0.1 M Tris-Cl at pH 7.25. Soluble fractions
are analyzed by SDS-PAGE (sodium dodecyl polyacrylamide electrophoresis) and visual-
ized after coomassie staining. Time-step for the highest expression is determined for each
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clone and another round of expression of is carried out under same conditions with larger
volumes. The expressions are terminated by centrifugation at 10,000 rpm for 15 min at 4oC
. Unless the samples are purified subsequently, the pellets are frozen at -20oC immediately
and kept at -80oC.
4.2.9 Lipase Purifications
Nickel coated beads of poly-histidine tagged proteins (GenScript) are used for affinity
purification of wild-type and mutants. Sodium phosphate buffer at 20 mM provided with
50 mM Imidazole during binding and 500 mM Imidazole during elution steps. 10 kDa
Filter Concentrators (Millipore) are used for buffer-exchange of 20 mM sodium phosphate
pH 8.0 against 500 mM Imidazole. The quantities of the purified lipases are measured in
Bradford protein assays [189] and sodium dodecyl polyacrylamide electrophoresis (SDS-
PAGE) is used to test the purity of the lipases. Stacking is made using 4% polyacrylamide
and size separatiion is made under 12.5%.
4.2.10 Lipase Assays
Lipase activity is determined in two different assays. In titrimetric assay, triacylglycerols
(TAGs) are used as substrates of lipase reactions. The liberated fatty acids are quantified
by direct titration with sodium hydroxide to thymolphthalein end point as described [190].
In fluorometric assay, 4-MU based substrates are used.
Titrimetric Assays
Lipase assays at saturating conditions are performed to measure steady state activities.
Specific activities of BTL2 and mutants are measured in enzyme assays using emulsifica-
tions of C4 and C8 TAGs at final concentrations of 100 and 150 mM with 5% (w/v) gum
arabic as stabilizer. Lipase activity at pH 8.0 is determined using purified lipases by direct
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titration of fatty acids as described [190] and 1 unit is defined as the amount of enzyme to
liberate 1 μmole fatty acid in 1 minute. The reactions are performed at room temperature
(∼ 300K) to be consistent with computational models and at 55oC. Because 6-8% change
in specific activities are observed for 100 mM substrate concentration, specific activities of
lipases are calculated at 150 mM substrate concentration and expressed in Units.mg−1 of
pure lipase. The assays are repeated for two times to test its reproducibility. Lipase activity
is also measured at 55oC at pH 8.0 using same titration procedure for all lipases. Assuming
all lipase bound to the lipid interface of substrate emulsion, the specific activity values re-
flect a measure from steady state and the fold changes in specific activities of mutants with
respect to wild-type correspond to the ratio of kcatmt/kcatwt , which affects the binding free
energy of ES‡ complex (ΔΔG‡) with a logarithmic factor [191] The Gibbs energy diagrams
for mutants are profiled using two terms, ΔΔGS and ΔΔG‡. ΔΔGS is the difference in the
binding free energy of mutants relative to wild-type and is calculated by SMD. ΔΔG‡ is
calculated by [192, 193],
ΔΔG‡T =−kbT ln(kcatmt/kcatwt ) (4.3)
Fluorescent Assays
For fluorescence assays, lipase activity is measured in a 96-well black micro-titer plate
using 4MU-butyrate and 4MU-caprylate as substrates. Cell-free expression medium is
assayed using different substrate concentrations in reaction medium of 100 mM Tris-Cl
at pH 7.25. Gemini XS (Molecular Devices) is used to measure 4MU-fluorescence using
an excitation wavelength of 355 nm and an emission wavelength of 460 nm in a kinetic
fashion. The measurements are made at every minute for 1 hour. All measurements are
performed in duplicates and initial velocities are calculated using SoftMaxPro Software
(Molecular Devices). Relative Fluorescence Unit obtained from fluorometer is converted to
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Figure 4.2: Standard Curve for RFU and 4-MU
4MU units according to the linear relationship shown in Figurefig4.2. Kinetic parameters
are obtained from Lineweaver-Burk plots.
4.2.11 Thermostability Analysis
Purified lipases are used in fluorescent assays to profile thermostability by quantifying the
residual activity of lipases after incubation for 30 minutes at temperatures of 60oC, 65oC,
70oC, 75oC and 80oC. The reaction is performed in a mixture of 250 μM substrate, 0.1
mM Tris-Cl pH 7.25 at room temperature. The percent activity is calculated by setting
60oC to 100%.
4.3 Results and Discussion
4.3.1 Characterization of Complex Molecules
Complex configurations are delineated to validate bound ligand in BTL2 cleft. Initially
using MD results preceding SMD, the cleft region is identified to comprise of four binding
pockets, three pockets for the acyl chains of TAG (sn-1, sn-2, sn-3) and an oxyanion hole
for head group. The catalytic cleft of BTL2 is formed to unite sn-1 and sn-3 pockets that
resembles boomerang i.e. two large crevices for three acyl chains in Figure 4.3.
The catalytic triad of BTL2 is formed by S114, D318 and H359. The investigations
of the computational models employed in this section ensure correct orientations of the
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Figure 4.3:
Top-view of the BTL2-C8 complex. BTL2 surface is shown in grey and C8 ligand is in
red stick model. To depict the boomerang shape of the cleft, sn-1, sn-2 and sn-3 acyl
chains are labeled.
catalytic triad residues (S114, D318 and H359) and ligands (Figure4.4). Decreased fluc-
tuations of active site residues (less than 1 A˚) also suggest tight packing of catalytic triad
as shown in Figure 4.5 A. Moreover, the head group atoms of sn-1 chain is shown to be
less mobile compared to acyl chain atoms in Figure 4.5 B. Decreased mobility in the active
site as well as the scissile fatty acid of both ligands reflects bound configuration for ES
complex for TAG hydrolysis.
4.3.2 PMF from SMD simulations
The pulling speed was another critical parameter that the accuracy of the free energy cal-
culations from SMD trajectories is valid only at very slow speeds [151]. However required
computer-power for slower rates exponentially increases. Therefore, a compromise is es-
sential between accuracy and cost. A study like ours would least likely to suffer from
such compromise. In our case, ranking of binding free energies of three different TAG
molecules to wild-type and mutant receptors was aimed. The speeds; 10 A˚/ns, 5 A˚/ns and
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Figure 4.4:
ES Complex for C4, C8 and C12. (A) C4, (B) C8 and (C) C12 TAGs are shown in stick
models (C: cyan, O: red, N: blue) along with active site residues to mark the catalytic triad
(S114, D318 and H359) couplings. Distances between sn-1 carboxyl oxygen and S114
side-chain hydrogen and between catalytic triad residues are shown with dashed lines are
also given in . The protonation of histidine in the active site of the enzyme-substrate
complex is replicated as shown here. For (C), histidine hydrogen are not shown.
Figure 4.5:
Fluctuations of Ligands and Active Site Residues. RMS fluctuations of the active site
residues (A) are plotted for 1 ns of equilibration with light bars for the BTL2-C4 complex,
and dark bars for BTL2-C8 complex. The fluctuations for acyl chain atoms of ligands (B)
are plotted using white bars for C4 and grey for C8.
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Figure 4.6:
Pulling Speeds for SMD. Work functions plotted against the reaction coordinate for C4,
C8 and C12 ligand at pulling speeds of 10 (green), 5 (blue) and 2.5 A˚/ns (red).
2.5 A˚/ns were used to calculate work values of attempted pullings for three ligands (Figure
4.6). To save computer power, 5 A˚/ns was found optimum for SMD.
The work functions obtained from ten SMD trajectories for the C4, C8 and C12 ligands
are shown in Figure 4.7. The PMF profiles calculated from these work functions using
Jarzynskis equality are indicated with black lines in the same figure, fromwhich the relative
binding free energies for the C4, C8 and C12 TAGs are found as -9.8, -17.9 and 21.2
kcal/mol, respectively. These results indicate that using ten samples is sufficient for the
purpose of ranking of all ligands.
It is noted that the catalytic cleft of BTL2 is 14 A˚ in-depth [33], but a flat PMF shape
in Figure 4.7 becomes evident only after a pulling distance of 25 A˚. To understand why
the dissociation of the ligands from BTL2 is delayed for another 10 A˚, the individual SMD
trajectories are inspected and it is found that despite the application of a unidirectional
force in the z-direction, in some of the pulling events, the ligand bends towards the lid
after coming out of the cleft and starts interacting with the hydrophobic residues on the lid
surface. This happens 3 out of 10 cases for C4, 6 out of 10 cases for C8, 5 out of 10 cases
for C12. One example of such a bent path for the C4 ligand is shown in Figure 4.8. In
reality, the lid may interact with several TAGs simultaneously, and it is difficult to estimate
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Figure 4.7:
PMF for C4, C8 and C12 TAG binding. Work functions plotted against the reaction
coordinate for C4, C8 and C12 ligand. The reaction coordinate is chosen as the cleft axis
and the initial reaction coordinates of both ligands are aligned in the catalytic cleft
according to their center of masses. PMF profiles of C4, C8 and C12 binding are
constructed from 10 work functions and shown in black.
the actual free energy of lid binding from SMD simulations. In any case, the binding of
single TAG to the catalytic cleft which corresponds to the affinity of ES complex at the
interface is investigated here. Thus, the cleft binding of the ligands from lid binding is
distinguished from each other. The free energy of cleft binding of TAG molecules from
the first 15 A˚ of the SMD extension is determined as -7.2, -15.2 and -18.0 kcal/mol for the
C4, C8 and C12 ligands, respectively. Comparing with the binding free energy obtained
from the full extension, the free energy for the lid binding can be estimated as about -2.6
kcal/mol for all TAGs. Thus, considering only the free energies of cleft binding does not
change ranking of the ligands.
All ligands have the same configurations for binding of the head group atoms to the cat-
alytic triad (Figure 4.4) but the C8 ligand has four extra hydrocarbons in the binding pocket
involved in hydrophobic interactions. This explains the larger affinity of C8 for BTL2 com-
pared to C4, similarly C12 has increased affinity for the cleft compared to smaller TAGs.
Because the binding affinity is overestimated in SMD calculations, especially for larger
ligands [148, 149], the binding free energy difference between C8 and C4 is taken as a
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Figure 4.8:
The Bent-exit of C4 from Catalytic Cleft. An example dissociation of C4 ligand from
catalytic cleft (i.e. pulling upwards) is illustrated. Displacement of COM of C4 ligand is
shown by color spheres and RGB color scheme for displacement of C4’s COM is scaled
in bar is used to color the COM spheres with respect to the corresponding distance from
the catalytic cleft during pulling. Lid helices is shown in blue to clarify the bending
towards them of C4 ligand’s COM towards these helices. CA atom of catalytic serine is
represented as magenta sphere to assess the cleft depth.
qualitative estimate rather than a quantitative prediction.
4.3.3 Catalytic Cleft of BTL2 and Selection of Mutants
Among three ligands, C4 and C8 TAGs are selected to investigate the chain-length selec-
tivity of BTL2 and C12 is eliminated in mutant analysis. The reason for not considering
larger molecules than C8 TAG (e.g., C12) is that the accuracy of the SMD method in free
energy calculations is reasonably good for small molecules but it becomes increasingly
unreliable for larger ligands [128,148,194] Moreover, BTL2 shows the highest activity for
C4 TAG followed by C8 which has half the activity of C4 [162] Thus, C4 and C8 TAGs
are considered as an optimum ligand pair to assess the chain-length selectivity of BTL2.
Chain-length selectivity is determined by the volume and the hydrophobicity of cat-
alytic cleft. By inspecting the SMD trajectories of TAGs, one can find the critical BTL2
residues involved in binding of the acyl chains. Positions of the critical residues identified
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Figure 4.9:
Mutant Selections. The initial structures of SMD method is shown for both ligands, (A)
C4 and (B) C8. The pulling direction is towards lower left corner of the Figs. The side
chains of the ligands and the selected residues are shown by stick models (C: cyan, O: red
and N: blue). The respective distances between the selected side chain atoms of the
residues and ligand atoms are given in units of Angstrom. These distances are measured
for the fourth and fifth carbons of ligand are represented by green and orange spheres,
respectively. Catalytic distance is also shown for S114 residue along with the orientation
of the double bonded oxygen of sn-1 chain towards main chain amide groups of F17 and
Q115 residues that form the oxyanion hole (in dashed circle).
from such a search are shown in Figure 4.9 for the C4 and C8 ligands. Because BTL2 is
regio-specific to sn-1 and sn-3 chains as most of the extracellular lipases [71], the catalytic
cleft is formed to unite the binding pockets for sn-1 and sn-3 in one large cavity. This
large cavity is lined with hydrophobic residues that interact with the sn-1 chain on one
side and sn-3 on the other side. Inspection of this cavity reveals that two phenylalanine
residues, F291 and F17, are involved in binding of the sn-1 and sn-3 chains, respectively,
each packing up to four carbon atoms (Figure 4.9). The cavity is surrounded by I320 at the
bottom and V175 at the end, which interact with the sn-1 chain, and L57 at the top which
interacts with the sn-3 chain. Although L360 is in the sn-2 pocket and not considered to
be critical for the catalytic machinery, it does have a close contact with the sn-2 acyl chain
(Figure 4.9), and therefore it is included in the list of mutations. Conversely, F291, which
is in close-proximity of the sn-3 chain of both ligands, is not considered for mutagenesis in
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Figure 4.10:
Pair Distances. The measurements of the distances between C8 ligand and the selected
residues are plotted against the extension in the reaction coordinate. Here C15, C25, and
C35 denote the fifth C atom of the chains sn-1, sn-2, and sn-3, respectively. Average
measurements for 5 pulling events for C8 ligand is used to measure the distances. The
pairs of atoms used in these distances are illustrated in the given snapshots of initial SMD
structures in Figure 4.4
order not to disturb the structural integrity of the catalytic cleft. To confirm the importance
of these five residues (F17, L57, V175, I320, and L360) in the binding of the TAGs, we
show in Figure 4.10 the pair distances between these residues and the fifth carbons of the
C8 ligand as a function of the pulling distance. Persistence of these contacts for several
indicates their importance in binding. To increase the selectivity of BTL2 for C4 over C8,
we consider mutation of the four aliphatic residues (L57, V175, I320, and L360) to pheny-
lalanine which will reduce the volume available for C8 but not C4, and hence decrease the
affinity of C8 relative to C4. An opposite mutation is performed for F17 (i.e., F17A) to
investigate the effect of volume increase in the cleft. Similarly two residues from the sn-1
pocket (V175 and I320) are mutated to alanine to test our mutagenesis strategy.
A total of 16 mutant complexes (combination of 8 lipases and 2 ligands) are investi-
gated to analyze the effect of the volume adjustments in all three binding pockets of BTL2.
Although, the geometry of catalytic triad is highly conserved, that of the binding pockets
are highly variable among lipases. The variable composition of the binding pockets gener-
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Figure 4.11:
Cloning Confirmations. Negative control ((-) ctrl) is PCR mix only whereas positive
control ((+) ctrl) is recombinant pMCSG-7 harboring wild-type BTL2. (A) Colony PCR
is performed for 9 clones with BTL2 LIC primer pair and (B) confirmation digests of the
pure plasmids are done using EcoRI and NdeI enzymes. Both analysis are made in
agarose gel under 100 V for 30 minutes.
ates an elastic environment for the acyl chains at various chain-lengths [41]. Thus, a large
number of mutants is required to clarify the function in such variable environments.
4.3.4 Mutagenesis and Production
Mutagenesis is carried out using OE-PCR strategy which is as effective as kit-based ap-
proaches [102] Because usage of ligation independent cloning is proved for efficient han-
dling of large number of clones [195], cloning procedures are ligation-free. Heterologous
expressions are performed in E. coli and recombinant lipases are tagged with poly histidine
at their N-terminus which allows one-step affinity purification.
Eight BTL2 variants -7 single and 1 double mutation- is generated in two PCR steps
and subsequently cloned to pMCSG 7 backbone using ligation independent sites. The
confirmations of mutant clones are given in Figure 4.11. One of the selected plasmid for
61
Figure 4.12:
LB-Rhodamine Plate Test for Expressions. After 2 days of incubation on LB-rhodamine,
the wild-type and mutant E. coli SHuffle clones are visualized under UV light.
Figure 4.13:
E. coli SHuffle Expressions. Whole cell-fraction from wild-type and mutants, collected
after 4 hours, analyzed in 12% (top) SDS-PAGE and (Bottom) zymography using
4MU-butyrate. SDS-PAGE is stained with coomassie and zymogram is performed under
UV light.
each mutant is sequenced and used as template of expression studies. Sequence confirmed
clones in E. coli SHuffle cells are tested against lipase activity and results are given in
Figure 4.12. This initial test of heterologous expression is positive for each clone except
for F177A (Figure 4.13). Thus, this mutant could not be considered in purification studies
(Figure 4.14).
4.3.5 Titrimetric Lipase Assays
The specific activities of BTL2 and its mutants are given in Table 4.4 for both substrates.
The specific activity towards C4 chains is enhanced for V175F mutant only whereas C4
activity is decreased for the mutants L57F, V175A, I320A and I320F/L360F. The rest of
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Figure 4.14:
Metal-affinity Purifications. SDS-PAGE result of purification of wild-type and mutant
lipases used in this section. First lane in both gels correspond to molecular weight marker
(SM0671), The samples are prepared in 0.1 Tris-Cl buffer at pH 8.0.
Table 4.4:
Titrimetric Assay Results. aSpecific activity (Units.mg−1) of BTL2 and its mutants is
determined in titrimetric assays at 25oC using C4 and C8 TAG substrates. The results are
averages and standard deviation of two independent assays.
Specific Activity (U/mg)
Tributyrin (C4) Tricaprylin (C8)
wild-type 583±16 164±19
F17A 518±122 598±26
L57F 369±175 177±93
V175A 399±36 150±39
V175F 1571±257 613±121
I320A 299±31 132±25
I320F 588±133 209±18
L360F 609±103 506±53
I320F/L360F 392±87 157±42
the mutations, F17A, I320F and L360F do not affect specific activity of BTL2 towards
C4. On the other hand, F17A, V175F and L360F increase C8 activity while others, L57F,
V175A, I320A, I320F and I320F/L360F do not show significant change in the specific
activity towards C8 chains.
BTL2 is thermostable lipase that has previously shown its highest activity at high tem-
peratures (50-60oC) and lipase activity is also measured at 55oC (Table 4.5). From these,
the double mutant which is the combination of I320F and L360F is found to be inactive at
55oC. The reactions when carried out at ambient temperatures, double mutant is compe-
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Table 4.5:
Fold-changes in Activity at Different Temperatures. NA: No activity. The fold-change in
the activity od mutants (see Table 4.4) are given with respect to a At 25oC specific activity
for BTL2 towards C4: 583 Units.mg−1 and towards C8:164 Units.mg−1. bAt 55oC the
specific activity towards C4: 1153 Units.mg−1 and towards C8: 532 Units.mg−1.
Lipases 25
oC 55oC
C4 C8 C4 C8
wild-type 1a 1a 1b 1b
F17A 0.89 3.65 0.43 1.18
L57F 0.63 1.08 0.77 0.75
V175A 0.70 0.81 0.75 0.68
V175F 2.69 3.74 1.02 2.39
I320A 0.50 0.81 0.33 0.30
I320F 1.01 1.27 1.07 1.04
L360F 1.04 3.09 0.97 1.08
I320F/L360F 0.67 0.96 NA
tent to hydrolyze both of the chains with a slightly increased selectivity towards C8 chains
whereas this double mutant is inactivated at higher temperatures like 55oC. This suggests
that double mutation in the catalytic cleft is likely to result in the loss of the tempera-
ture activity of lipase. Conversion of the aliphatic residues to bulk phenylalanines in the
catalytic cleft may have a negative influence on the flexibility of the catalytic cleft [156].
Only, V175F shows differential chain-length selectivity at high temperature. The selectiv-
ity shifts to C8 at high temperatures for this mutant. Two explanations previously made
by Jeong et. al. can account for this discrepancy observed for V175F which is found in 2
residues away from the N-terminus of the first lid helix: The hydrophobic residues may en-
hance lid interactions with the insoluble interface at high temperatures and may interfere
with the interfacial activation process [156]. In these aspects, V175F can be considered
critical for interfacial activation. Another point to support this result can be unchanged
V175A selectivity at high temperatures. With respect to the hydrophobic interactions dis-
played by V175A which is weaker than V175 and much weaker than V175F.
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4.3.6 Kinetic Parameters towards 4MU-esters
Fluorescent assays are also performed for all lipases using 4MU-butyrate (C4) or 4MU-
caprylate (C8) as substrate to find the chain-length selectivity for acyl esters of fatty acids.
The selectivity constant, kcat/KM is derived from the double reciprocal 1/[V ] vs. 1/[S]
(Lineweaver-Burk) plots of the kinetics of 4MU production. 4MU-butyrate (C4) or 4MU-
caprylate (C8) are used in fluorescent assays to find the chain-length selectivity towards
acyl esters of fatty acids. The most significant changes are observed for I320F for which
the selectivity constant is increased by 8-folds for butyric acid methyl ester (C4) (Table
4.6. Experimental quantification of the dissociation constant for ES complex, KS (when
KM = KS) is trivial for most of the metabolic enzymes having water soluble substrates yet
it is a challenge for TAG hydrolysis because the hydrolysis is essentially carried out at
water-lipid interfaces. Therefore, kinetic parameters, particularly KS, for TAG hydroly-
sis is commonly approximated using single-chain esters of p-nitrophenyl or umbelliferyl
that mimics scissile fatty acid (sn-1 chain for BTL2) [196]. Although hydrolysis of these
substrate analogs is presumptive only for lipase activity, kinetic parameters for triacylglyc-
erol hydrolysis cannot be determined accurately using such analogs. More importantly,
Schmidt-Dannert et. al (1996) reported that chain-length selectivity of BTL2 is varied
among triacylglycerols and p-nitrophenyl based substrates [197]. Thus these fluorescent
assays are performed to see the effects of these mutations on fatty acid methyl esters rather
than to validate the computational findings.
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Figure 4.15:
Thermostability of Mutants. Each lipase is incubated at the given temperature for 30
minutes using 4MU-caprylate as substrate. Assays are performed at pH 7.25 and room
temperature. Percent activity is shown with error bars representing standard deviations
from duplicate measurements. The highest activity for each mutant is set to 100%.
4.3.7 Thermostability of Mutants
The thermostability of each mutant is also profiled to see the effects of the mutations. All
of the mutants are found restore at least 50% at the temperature range of 60-65oC (Figure
4.15).
4.3.8 Affinities of C4 and C8 for BTL2 Mutants
PMF profiles for mutant BTL2 are constructed from five pulling SMD trajectories and
illustrated in Figure 4.16 A and B for C4 TAG and C8 TAG, respectively.The relative
binding free energies of both TAGs for mutant BTL2s are determined at 15 A˚ of extension
as in wild type BTL2, and the values are listed in Table 4.7. The mutations are chosen
such that they will reduce the affinity of C8 but wont have an adverse effect on the binding
of C4. As seen from Table 4.7, this expectation has mostly borne out; the affinity of C4
has increased for all mutants except for V175F and the affinity of C8 has decreased for
all mutants except for I320F. Among the favorable mutations for C4 over C8 selectivity,
L360F provides the most promising candidate followed closely by F17A.
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Figure 4.16:
Mutant PMF Profiles. PMF profiles of the mutants, F17A, L57F, V175A, V175F, I320A,
I320F, L360F and I320F/L360F are shown for C4 ligands (A), C8 ligand (B) in color
series and PMF profile of wild-type is plotted in black color to compared the relative
changes in the binding free energy. 5 samplings are used to construct mutant PMF
profiles.
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Figure 4.17: Interfacial Kinetics.
Figure 4.18: Kinetics at the Interface.
4.3.9 Activation Barrier in C4 and C8 Hydrolysis
The experimental determination of lipase kinetics is quite labor-intensive because the phys-
ical properties of the lipid substrates might pose extra challenges in the assays. Moreover,
accurate determination of the activation barrier for the hydrolysis reactions might not be
possible in a straightforward manner due to two sequential interactions of the lipase with
the lipid substrates in the interfacial kinetics model (Figure 4.17). Therefore, in this thesis
we do not determine the kinetic parameters for wild-type and mutants in the usual way. In-
stead we aim to obtain a relative estimate of the activation barrier in mutants with respect
to wild-type for C4 and C8 TAG. If we consider the activated lipase, the scheme in Figure
4.17 simplifies in to Figure 4.18.
This activation barrier (ΔG‡T ) to be estimated is composed of two terms, the binding
energy of ES complex (ΔGS) and the energy required for transformation of substrate to
transition state (ΔG‡).
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ΔG‡T = ΔG
‡+ΔGS (4.4)
According to equation 4.4, we had to estimate two parameters: the substrate binding
affinity (ΔGS) and the activation energy (ΔG‡) of the hydrolysis. The former (ΔGS) cor-
responds to the binding affinity of ES complex whereas the latter (ΔG‡) corresponds to
that of ES‡ complex. Here, we have used a computational model to estimate the binding
affinity of ES complex since it corresponds to the single TAG binding to catalytic cleft of
BTL2. The estimation of the binding affinity of ES complex provides us with the binding
constant. The binding constant for ES complex is given as follows in Michealis-Menten
scheme [198],
KS = k1/k−1 (4.5)
But if we consider the revision made by Briggs and Haldane, the equation 4.5 is rewrit-
ten as following [199],
KS ≈ KM where k−1  k2 (4.6)
In this aspect, we are able to determine the binding free energy of substrate which
indeed gives us an estimation of KS. To predict the kcat constant, which will gives us the
estimate of the second term: the activation energy (ΔG‡), we have used two different assays
at saturating substrate conditions. Since, we have observed less than 10% of change in the
V0 at two different substrate conditions, it is assumed that the steady state conditions are
reached for which the total enzyme concentration is given as,
[E0] = [ES] (4.7)
and rate reaction is measure of turnover at saturating substrate conditions,
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[S]≈ KM, ν =
kcat
E0
(4.8)
Equation 4.8 gives us the estimate of the activation energy since the activation barrier
is given as,
ΔG‡T =−kBT ln(kcat/KM) (4.9)
where kB is the Boltzmann constant and T is the absolute temperature.
According to ref. [200], deacylation is substantially slower irrespective of the chain
length of triacylglycerol substrates. The change of the activation energy of catalysis is
typically given by comparing kcat/KM of mutants with wild-type at conditions where S<<
KM so that kcat/KM is acquired under saturating conditions. Here, we couldn’t measure
kcat/KM directly because the emulsion led to inconsistencies. Instead, we calculated KS
and assumed it was KM by the assumption that k2 << k−1. Also, we calculated kcat directly
under saturating conditions, thus we are assuming that there are no allosteric interactions
or feedback-related changes of rate.
In TAG hydrolysis, substrate in the ES complex is found in the unaltered form which
changes to transition state in the ES‡ complex. With respect to this paradigm, at a given
substrate concentration, catalytic preference depends on the individual binding free ener-
gies of ES and ES‡ complexes (ΔGS and ΔG‡) [191]. We have calculated the former using
SMD with Jarzynski’s equality and the latter is measured in experiments quantifying spe-
cific activities for all mutants. The fold changes in these activity values with respect to
wild type BTL2 should correspond to relative contribution of mutant ES‡ complexes to
ΔΔG‡ [191, 192]. From the values given in Table 4.8, we see that variations in specific
activities are relatively smaller (<5-fold, < 1 kcal/mol) for both substrates, suggesting
negligible contributions from ΔΔG‡ to ΔΔG‡T (Table 4.8).
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Table 4.8: Gibbs Diagram Values. Units are kcal/mol for whole table. aΔΔGS are calcu-
lated by ΔGS values for mutants with respect to wild-type in Table 4.7. bΔΔG‡ values are
calculated using the fold changes in specific activity of mutants with respect to wild-type
with an exponential factor. cΔΔGT ‡ is calculated from the Equation 4.4.
Lipases Tributyrin (C4) Tricaprylin (C8)
ΔΔGaS ΔΔG‡ ΔΔG
‡
T ΔGaS ΔΔG‡ ΔΔG
‡
T
F17A -0.6 0.1 -0.7 2.2 -0.8 1.4
L57F -0.7 0.3 -0.4 0.7 0.0 0.7
V175A -0.8 0.2 -0.6 1.2 0.1 1.3
V175F 1.9 -0.6 1.3 1.3 -0.8 0.5
I320A 0.0 0.4 0.4 -0.3 0.1 -0.2
I320F -0.2 0.0 -0.2 -2.0 -0.1 -2.1
L360F -2.5 0.0 -2.5 1.2 -0.7 0.5
I320F/L360F -1.2 0.2 -1.0 -2.2 0.3 -1.9
In contrast, variations in the binding free energies of mutant ES complexes (> 2 kcal/mol)
have greater effect on the catalytic preference (Table 4.8 and Figure 4.19). Thus the relative
binding free energy of the ES complex is much more critical than that of ES‡ for assessing
catalytic preference of C4 and C8 TAGs, particularly for the BTL2 mutants considered in
this study.
4.3.10 Chain-length Selectivity of Mutants
Among the four mutations carried out in the sn-1 pocket (V175A, V175F, I320A and
I320F), I320A and I320F do not have any significant effects on catalytic preference to-
wards C4 TAG (Figure 4.19), consistent with our strategy that volume adjustments near
I320 should not influence C4 affinity. Moreover, I320A mutant does not affect C8 prefer-
ence which indicates that alanine substitution at this position has a null effect on interac-
tions with TAG. Surprisingly, I320F mutant enhances the catalytic preference towards C8
(negative ΔΔG‡T ). It appears that I320F creates a more hydrophobic environment for the
acyl chain without restricting the available volume (Figure 4.9), which helps to increase
the affinity of C8. Thus, contrary to our expectations, phenylalanine substitution in I320 is
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Figure 4.19:
Gibbs Energy Diagrams of Hydrolysis Reactions. Gibbs energy diagram of C4 and C8
TAG hydrolysis for each lipase are given and normalized to the level of ES complex
formed by BTL2. Binding free energy changes of ES complex formed by lipases are
determined using SMD calculations and the binding free energy changes of transition
state complex of the lipases are is calculated by the fold-changes in the specific activities
of mutants with respect to wild-type for each substrate (Table 4.4). The catalytic
preference of hydrolysis are calculated from Equation 4.4 Table 4.7 is used for all of the
values used to rank enzyme, substrate (E+S) and transition state complex (ES) relative to
enzyme-substrate complex (ES‡).
not effective in reducing the cleft volume for C8.
Another residue in the sn-1 pocket, V175, is located in the loop connecting to the
N-terminus of α6 helix of lid which is not close to the oxyanion hole (Figure 4.9). The
position V175 is investigated in two mutations, V175A and V175F. Comparing the relative
affinities of the ES complex formed by V175F (Table 4.6), we observe a weaker binding
of both TAGs to the mutant form than BTL2, resulting in a decrease in the catalytic prefer-
ence towards both TAGs (Figure 4.19). It appears that V175F reduces the available volume
for both C4 and C8 ligands, and therefore is not very useful for boosting the selectivity of
C4 over C8. For V175A, on the other hand, the binding affinity and catalytic preference
are enhanced for C4 but reduced for C8 (Figure 4.19 and Table 4.7). V175A leads to in-
significant volume change in the cleft, and thus is not expected to have an effect on C4/C8
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selectivity. The fact that it does indicates that V175 is the optimal residue for C8 at this
positionchanging it to phenylalanine reduces the volume available to C8 while changing
to alanine reduces the hydrophobic interactions. In contrast, V175 appears to be volume
limiting for C4 binding, so its mutation to alanine improves the binding affinity. The muta-
tions carried out in the sn-3 pocket; F17A and L57F decrease catalytic preference towards
C8 and increase it towards C4. For F17A mutation, although a volume increase in the sn-3
pocket is presumed to enlarge cleft volume, the preference towards C8 chains is reduced
while it is increased for C4 (Figure 4.9) indicating that F17A actually reduces the stabi-
lization of C8 while slightly increasing it for C4. The chain-length selectivity is changed
for L57F similarly but not as pronounced as F17A. Compared to F17, L57 is positioned
further from the C8 chains (Figure 4.9), and this explains the less pronounced effect of
L57F on C8 binding. Due to its position in the sn-2 pocket, L360 is not considered to be
a critical residue for the catalytic machinery, yet L360F increases the catalytic preference
towards C4 the most while reducing it towards C8 (Figure 4.9 and Table 4.7). The finding
for C8 is consistent with our mutagenesis strategy of restricting the volume available to C8
but the increase in the binding affinity of C4 is unexpected. Clearly phenylalanine provides
a more favorable hydrophobic environment for C4 than valine does. The net result is that
L360F provides the most favorable mutation in BTL2 for boosting the enzyme selectivity
for C4 over C8.
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5 IMPACTS OF THE LID TRYPTOPHANS
ON THE ACTIVITY, STABILITY AND
AGGREGATION
5.1 Summary
Here, the lipase originating from Bacillus thermocatenulatus (BTL2) is a thermoalka-
lophilic enzyme that exhibits aggregation behavior and is stable at high temperatures [201].
Aggregation might be a strategy for thermostability and this process might involve hy-
drophobic interactions as a result of high hydrophobic amino acid content (33.2%) in
BTL2. Particularly, the lid region in BTL2 are rich in aromatic residues which might be
involved in these hydrophobic interactions that may be critical to the aggregation. In this
sense, we find two conserved tryptophan (W212 and W235) in the BTL2. Previously, tryp-
tophans are found in many regulatory functions in the lipase structure, especially the ones
that are found in the lid region. From this perspective, these tryptophans in the lid region
of BTL2 are of particular importance in this chapter. Via protein engineering approaches
we have obtained three recombinant lipases (wild-type, W212A and W235A mutants) and
characterized all of them in a series of assays for thermostability, thermoactivity and ag-
gregation. Molecular dynamics is also used to see the molecular impact of W212A on the
dimer stability of BTL2.
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5.2 Methods
5.2.1 Mutagenesis, Expression and Purification
Cloning strategies, production and purifications are explained in Chapter 4.2. Here, the
procedures are performed similarly with the only modification in the site-directed muta-
genesis step: The mutagenesis with OE-PCR is carried out using the mutant primers pairs
given in Table 5.1.
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5.2.2 Lipase Assays
Titrimetric lipase assays are performed to measure rate of reactions using C4 and C8 TAGs
as substrates at 150 mM in the presence of 5% gum arabic. The reaction conditions given in
Chapter 4.2. For fluorescence assays, lipase activity is measured in a 96-well black micro-
titer plate using 4MU-caprylate as substrates in 100 mM Tris-Cl at pH 7.25. Gemini XS
(Molecular Devices) is used to measure 4MU-fluorescence using an excitation wavelength
of 355 nm and an emission wavelength of 460 nm in a kinetic fashion. The measurements
are made at every minute for 1 hour for all analysis. All measurements are performed
in duplicates and initial velocities are calculated using SoftMaxPro Software (Molecular
Devices).
5.2.3 Thermostability and Thermoactivity Assays
Purified lipases are used in fluorescent assays with 4MU-C8 to determine the optimum
temperature range for their stability and activity. Thermostability is profiled by quantify-
ing the residual activity of lipases after incubation for 30 minutes at the given temperatures.
In the temperature activity assays, eight measurements (including time zero) in 7 minutes
are carried out for each temperature and fluorescence produced at each interval (1 min) is
captured by the termination of enzymatic activity in diluted HCl (10 mM). After all mea-
surements from each temperature are completed, end-point assays is performed in Gemini
XS fluorometer at high sensitivity.
5.2.4 ANS Fluorescence
Fluorometry is performed by the described procedure in the ref. [202]. In this procedure 1-
anilinonaphthalene-8-sulfonate (ANS) is used as the fluorescent probe and the fluorescent
readings are conducted via Gemini XS fluorometer at the excitation wavelength of 360 nm
and the emission of 460 nm. Three lipases are added to the final concentration of 50 μM in
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10 mMTris-Cl at pH 7.25. ANS is supplied at 50 μM in the mixture. The protein solutions
are incubated at the corresponding temperatures without ANS and then left for 5 min in
the presence of ANS before readings. The fluorescence is normalized to the background
ANS fluorescence collected from samples without protein.
5.2.5 CD Spectra
CD spectra are collected for samples, BTL2, W212A and W235A using J-815 Circular
Dichroism Spectropolarimeter (Jasco) in N2 atmosphere. CD spectra is collected in the
190-350 nm with 1.0 mm path length cuvettes containing maximum 10 μM of lipase.
Three tracings are used to collect final spectra for far-UV which is corrected for the back-
ground. Mean residue ellipticity [θ ] is calculated from the equation below,
[θ ] = 100×θ ×M/(C× l×n) (5.1)
100 is the correction factor for the cell length which is given as l in centimeters, M is
the molecular mass which 43 kDa for BTL2, n is the number of residues which is 389 for
BTL2 and C is the concentration in mg/ml.
5.2.6 Dynamic Light Scattering
Dynamics light scattering (DLS) is conducted using Zetasizer Nano XS (Malvern Instru-
ments). Filtered samples are contained 10 μM lipases in 10 mM Tris-Cl at pH 7.8. The
data analyses are performed using corresponding software supplied. DLS data is used to
analyze the change in the aggregation behavior of BTL2 and its mutants but not to deter-
mine molecular weight of the samples. The hydrodynamic radius (RH) of samples and the
standard deviation of the radius (CP) are collected from the mean value of the monomodal
peaks and from the width of the those peaks, respectively. CP/RH ratio is used as the poly-
dispersity index (PDI) which is a measure of aggregation. Lower values than 15% in PDI
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is used as the cutoff value for monodisperse samples [203]. The statistical parameters gen-
erated by the analysis software are interpreted by the analysis software (Zetasizer Nano).
DLS data obtained from the cumulant analysis are shown on correlograms for the quality
of the measurements and samples. The correlation function and cumulants fits data found
in the datalog, are used to assess the quality of the results. The completeness of the corre-
lation function and the goodness of the fit of each measurement are shown in the Appendix
A.2 for each measurement.
5.2.7 Zinc Tolerance
The crystal structure of this lipase has two different metal ions (zinc and calcium) thus
the effects of zinc on wild-type and W212A activity is investigated and the percentage
hydrolysis of 4MU-C8 substrate is calculated. The lipases are supplied at 10 nM in assays
and the chloride salts of calcium and zinc are supplied in a concentration gradient from 0.6
mM to 5 mM.
5.2.8 Molecular Dynamics and in-silico Mutagenesis
To understand the molecular basis of W212A mutation in dimerization, we have performed
molecular dynamics (MD) with closed structure of Bacillus stearothermophilus L1 lipase
(PDB ID: 1KU0) [156] which has 98% of sequence homology with BTL21. This structure
is found in the dimer form composed of two lipase molecules as crystallographic asymmet-
ric units. The dimer structures are used in MD studies in the absence of external forces.
The dimer systems are composed of 60,000 atoms placed in a water box with dimensions
73x82x91 A˚3. 4 different systems are generated: 2 for the wild-type dimer with or without
Zn and 2 for the W212A mutation with or without Zn. The dimer has W212A mutation
in chain B for which W212 is found at the dimer interface both chains. The systems are
1The sequence alignment is given in Figure 3.2
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generated after solvation with a 100 mM NaCl solution. We have performed MD simu-
lations for the resulting systems using the NAMD program [130] with the CHARMM22
parameters [204,205] which include the CMAP correction [206,207]. An NpT ensemble is
used in MD simulations with periodic boundary conditions, and the long-range Coulomb
interactions are computed using the particle-mesh Ewald algorithm. Pressure is kept at 1
atm and temperature at 300K using the Langevin pressure and temperature coupling. A
time step of 2 fs is used in all MD simulations. The trajectory files are obtained in every
2000 fs. Following a 2000 step energy minimization, the dimer systems are simulated for
10 ns. In both systems, root mean square displacements are measured for the backbone
atoms C, N, CA.
5.3 Results and Discussion
5.3.1 Structural Investigation of W212 and W235
The tryptophan found in the lid region of BTL2 are investigated using the open (PDB ID:
2w22) [33] and closed conformation (PDB ID: 1KU0) [156] of lipase structures. These
two structures of BTL2 and L1 lipase share 95% sequence homology. These investigations
might reveal useful information at the atomistic level. Figure 5.1 gives the open and closed
structures. The lid region, active site and two tryptophan are shown in Figure 4.6 to see the
differences in W212 and W235 residues with respect to open and closed states. Although
the contacting residues for W212 are increased in the open state, the bulky side chain in
W212 shows the same conformation in the both states (Figure 5.1). However, it is not the
case for W235. The side-chain of this tryptophan is not rigid such that it is exposed to
solvent in the open state whereas it is buried in the closed state. According to the Figure
5.1, the activation BTL2 includes the movement of the bulky side chain ofW235 and owing
to its exposed side chain in the open state, W235 is a candidate to mediate the hydrophobic
interactions taking place at the substrate interface. In this regard, we start with the activity
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Figure 5.1:
Lid Tryptophans in the Closed and Open Forms. Closed (PDB ID: 1KU0) and open (PDB
ID: 2W22) states are shown in cartoon and lid region is colored in orange for both. The
lid tryptophan and the active site residues are labeled.
assays to observe impact of the W235A mutant on the lipase activity and chain-length
selectivity.
On the other hand, W212 does not change its conformation in the open state, in fact
W212 side chain is found buried in both of the crystal structures 1KU0 and 2W22. In
the former, W212 is found in the dimer interface (Figure 5.2) and in the latter it is found
covered by one of the lid helices (Figure 5.2). Conversely, W212 is found buried in the
open state whereas it is partially buried in the closed state. Unlike to W235, it seems that
the bulky side chain of W212 is not available for the hydrophobic interactions taking place
at the interface to modify the chain-length selectivity. Nevertheless W212 might form
other interactions that are required for the overall stability of the lipase since it decreased
the overall lipase activity without affecting the chain-length selectivity. W212A has its
side chain partially buried in the closed state whereas in the open state, W212 is buried
under the short lid helix (α6). In this sense, W212 might be contributing to the stability
of the open conformation. In the same sense, the closed structure [156] crystallized in the
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Figure 5.2:
W212 at the Dimer Interface. 1KU0 structure is shown in cartoons revealing secondary
structures for chain A (blue) and chain B (red). Yellow is used to color the lid region
(residues 175 to 240) for both. The tryptophan in chain B is 3 A˚ apart from G275 in chain
A.
dimer form at the interface that W212 in chain B is found in the close proximity to other
chain (Figure 5.2). Similar to the open state (2W22), W212 is found partially buried by
the intra-molecular interactions in the dimer. These structural investigations of the closed
and open conformations as well as dimer forms of this lipase support the idea that W212
might still be critical to other macroscopic properties of BTL2 such as thermostability and
aggregation [201].
5.3.2 Cloning, Expression and Purification
The analytic agarose gel results are given in Figure 5.3 for LIC of W212A and W235A.
Two selected positive clones are sequenced in both directions. The mutations are confirmed
similarly by BLAST. Expressions are confirmed in LB-Rhodamine plates and mutant li-
pases are visualized in SDS-PAGE and zymogram (Figure 5.4). These results confirm the
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Figure 5.3:
Cloning Confirmations. (A) Colony-PCR reactions using three colonies for W212A and
W235A transformants. Negative control lanes given as (-) ctrl are performed to test
carry-over contamination from primers. First lane is for forward primer and second is for
reverse. The expected size for both mutants is 1200 kb. (B) 3 recombinant plasmids from
each mutant are co-digested by EcoRI and NdeI. The positive clones should give two
fragments at 5900 kb -backbone- and 1300 kb -insert-. (-) ctrl is empty vector. The first
two positive colonies are selected for sequencing. The electrophoresis is performed at 100
V for 30 minutes using TBE buffer. DNA-Ruler 1 kb ladder (SM0311 Fermentas, see
Appendix A.1) is used for molecular weight references.
functional expression of these mutants in this heterologous host. Subsequently lipases are
purified (Figure 5.5) following similar techniques explained in Chapter 4.2.
5.3.3 Chain-length Selectivity
Triacylglycerols are the natural substrates for lipases. BTL2 has shown to have the highest
activity towards tributyrin (C4) and half of that activity towards tricaprylin (C8) [162]. The
rate of hydrolysis is measured for all lipases by titrimetry using emulsified tributyrin (C4)
and tricaprylin (C8) substrates at 55oC. The results are given in Figure 5.6 and suggest
that both of the trp mutants decrease C4 activity compared to wild-type BTL2. Tricaprylin
activity, on the other hand, is not affected by W235A but is decreased by W212A. Con-
sidering W235A mutation, it seems that this tryptophan is required for efficient hydrolysis
of tributyrin whereas W212A has negative impacts on the overall lipase activity regardless
of the chain-length of the substrate suggesting that W212A might have affected the overall
85
Figure 5.4:
Expression Analyses. (A) W212A and W235A containing SHuffle E. coli cells are plated
on LB-rhodamine and the lipase expression is monitored under UV. (B) SDS-PAGE result
of W212A ad W235A expressions. Fermentas SM0671 (see Appendix A.1) is used for
molecular weight determination. Soluble fractions are obtained from samples of 2 and 4
hours of expression. (C) Zymography analysis is performed using 4-MU-butyrate. The
samples obtained from 4th hour are used for large volume expressions of W212A and
W235A.
stability of the lipase at 55oC but not chain-length selectivity of the lipase. According to
the comparative analysis of the closed and open lipase structures (Figure 5.6), W235 is
considered to be a candidate residue for interfacial binding of BTL2 to substrate interface.
Together with activity analysis, we infer that W235 is a critical position for the interfacial
binding of tributyrin but not for tricaprylin and alanine substitution at this position might
have resulted in the loss of the hydrophobic interactions at the tributyrin interface and thus
in the decreased activity. Similar to W235A, Humicola lanuginosa lipase contain a trypto-
phan in its lid region and mutation of W235 has similarly resulted in a substantial loss of
activity towards tributyrin [200]. This indicates that W235 is essential for the distinct C4
selectivity displayed by BTL2.
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Figure 5.5:
Purification Results. (A) SDS-PAGE result of purification of wild-type lipase. 5
ml-HisTrap column is used for purification and elution is performed in 20 ml by
collecting 0.75 ml fractions. Lane 1 is for molecular weight marker (SM0671). First 9
fractions are loaded in 2-10 lanes of SDS-PAGE gel. (B) Purification of W212A and
W235A mutant lipases are shown in SDS-PAGE analysis. 1 ml-HisTrap columns are used
for purification. Elution is performed in 5 ml by collecting ten of 0.5 ml of fractions. First
seven fractions are used in SDS-PAGE. Lane 8: molecular weight marker (SM0671,
Appendix A.1), lane 1-7: fractions of W212A and lane 9-15: fractions of W235A.
Figure 5.6:
Titrimetric Assay Results. The lipase activity is shown as the titrated fatty acid amount
versus time for BTL2 (black), W212A (red) and W235A (blue) using C4 and C8
substrates. The reaction rate (v) is calculated by the slope of the linear fitting functions.
The cut-off value for R2 is set to 0.97 and at least three time points are used for linear
fitting.
87
Figure 5.7:
Temperature Activity. The highest activity is set to 100% and percent hydrolysis of
4MU-caprylate is plotted against the reaction temperature. To find out Topt of wild-type,
W212A and W235A mutant lipases, temperature range of (A) 40-80oC is scanned by
10oC steps. Error bars show the results of two experiments. (B) 50-70oC is scanned by
5oC steps for BTL2 and W235A.
5.3.4 Temperature Activity Assays
Temperature activity assays are performed to determine the optimum temperature (Topt)
for lipase activity. Figure 5.7 A demonstrates that Topt is 50oC for W212A and 60oC for
BTL2 andW235A. Further investigation of the 50-70oC range (Figure 5.7 B) for BTL2 and
W235A reveals that BTL2 has a Topt of 64oC whereas W235A has showed highest activity
at 60oC. Moreover, W235A is more tolerant than BTL2 at the range of 50-62oC. Not shown
in Figure 5.7 B but W212A has showed its highest activity at 50oC, in agreement with its
profile given in Figure 5.7 A. These findings suggest that W235A mutation has slightly
affected the thermoactivity whereas W212A has decreased Topt about 10oC. Among two
trp mutants W212A is much more critical than W235A. Although temperature activity
assays are performed with fluorescent substrates the overall findings correlate with the
finding that W212A mutation is likely to result in the destabilization of the lipase structure
at high temperatures.
88
5.3.5 Effects of Temperature on the ANS Binding
Three lipases are used at 50 μM in fluorometry at different temperatures using ANS as the
fluorescence probe for aggregation. Figure 5.9 shows the fluorescence spectra of ANS at
460 nm in the presence of only lipase (white squares) and lipase+5% 2-propanol (black
squares). 2-propanol is known to prevent BTL2 from aggregation in aqueous media [203].
In that study, concentrated BTL2 has been shown to be in monomer form in the presence of
5% of 2-propanol. Relying on this, 5% 2-proponal is used as the inhibitor of the aggrega-
tion of BTL2 in ANS binding assay. ANS binds to hydrophobic regions in protein surface
with high affinity and its fluorescence intensity is significantly increased upon binding to
low polarity regions in a protein surface [208]. This makes ANS particularly suitable for
the estimation of the surface properties of proteins [209, 210]. ANS and protein-protein
interactions -as in aggregation- compete for the similar hydrophobic regions in the sur-
face of BTL2 thus ANS can also be used to probe aggregation [211–213]. According to
ANS spectra, the aggregation behavior of BTL2 is clearly dependent on the temperature.
At increased temperatures like 65oC and 75oC, ANS binding increases which is an indi-
cation of deaggregation (Figure 5.9). Additionally, BTL2 activity which is proportional
to the available active sites - is significantly enhanced in the presence of 1% cholate2 at
low temperatures whereas activity is increased slightly at high temperatures. Both from
the reference and the ANS spectra of BTL2 as a function of temperature agree that BTL2
molecules tend to aggregate at low temperatures. This inference can also be made from the
reference that investigates the aggregation and activity relationship of BTL2 [201].
Although it is not possible to comment on the oligomeric form of BTL2, whether it
is composed of monomers or dimers, only by looking at the ANS spectra, increased ANS
fluorescence reflects an increased binding surface for ANS and thus could be used to com-
pare the BTL2 and mutants by means of their available surface for ANS binding and thus
2Cholate is a bile salt and known to inhibit aggregation of BTL2, similar to 2-proponal
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Figure 5.8:
ANS Fluorescence Spectra. ANS binding is shown as a function of temperature for three
lipases. The plots are generated using mean values of duplicate assays. White squares
corresponds to measurements of only proteins and black squares correspond to the
measurements of proteins in the presence of 2-proponal as an inhibitory reagent for
aggregation of BTL2 [203].
their aggregation tendency. As can be seen in Figure 5.9, binding of ANS to the BTL2 is
higher (2-folds) in the presence of 2-proponal at both temperatures 65oC and 75oC. This
substantial increase in ANS binding in the presence of 2-proponal indicate that the surface
hydrophobicity of BTL2 molecules is shielded by aggregation. Similarly, ANS binding to
W235A is increased at 60oC in presence of 2-proponal but it shows a decrease at 75oC in
the presence of 2-proponal, unlike to BTL2. This might be a result of thermal denaturation
of this mutant below 75oC. Interestingly, W235A shows a decrease in the fluorescence
when treated with 2-proponal which is known to inhibit aggregation of BTL2. But aggre-
gated W235A does not show any decrease in the fluorescence suggesting that aggregation
may be retarding the thermal denaturation in this mutant. Lastly, W212A has resulted
in undifferential ANS spectra at different temperatures or in the presence of 2-proponal.
This unaltered ANS binding can be explained by the little tendency of this mutant to form
aggregates since 2-proponal has no effects on the fluorescence intensity in W212A. More-
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over, at 55oC ANS binding in W212A is one fold higher than those of BTL2 and W235A,
suggesting ANS binding is higher at 55oC is not competed by other lipases in solution and
aggregation is inhibited by W212A.
5.3.6 CD Spectra
To comment on the overall secondary structure of the trp mutants with respect to wild-type,
the far UV CD spectra are collected using 10 μM of lipases. Far-UV CD spectra in the
190-250 nm corresponds to the absorption of amide groups and will be used to report the
secondary structure of proteins [214]. Typically, all α-helical proteins give two bands of
similar magnitude at 222 nm and 208 nm which is accompanied by a positive band around
190 nm. All β -sheet-sheet proteins generally show a negative band between 210-220 nm
and a positive one between 195-200 nm nevertheless CD spectra for β -sheet proteins may
vary more than that of α-helical proteins due to diverse β -sheet configurations in proteins
such as parallel, antiparallel or mixed [214]. Keeping these in mind, the far-UV CD spectra
of BTL2 (black), W212A (red) and W235 (blue) are shown in Figure 5.8. Ttwo charac-
teristics of a-helical structure is faint but visible around 208 and 222 nm for BTL2 and
W235A. These two lipases also yield a positive band at 190 nm which confirms the pres-
ence of helical content for the lipase structure. With respect to β -sheet characteristics, the
given CD spectra in Figure 5.8 is no different from each other. The secondary structure of
W235A is similar to the wild-type yet W212A appears to be different from wild-type spec-
tra suggesting an instable structure for this mutant. Further investigations are conducted to
elucidate the role of W212 for the stabilization of the overall structure.
5.3.7 Effects of Aggregation on Temperature Stability
The thermostability assays are performed by incubating lipases at two different concentra-
tions. Since aggregation is positively correlated with the concentration, we expect to see
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Figure 5.9:
Far-UV CD Spectra. BTL2 (black), W212A (red) and W235 (blue) symbols corresponds
to mean residue ellipticity [θ ] as a function of wavelength, λ . The spectra of each lipase
is subtracted from blank spectra collected for the buffer system. Data steps for each
measurement is 1 nm.
the effects of the aggregation on the thermal stability in these assays. The concentration
of BTL2 is increased from 1 μM to 50 μM during thermal incubation to test the effect of
aggregation on the thermostability. The results are shown for all lipases in Figure 5.10.
BTL2 and W235A restore at least 75% of total activity at 65oC at 50 μM but this tolerance
is almost absent for both when they are incubated at 1 μM concentrations (Figure 5.10).
Clearly, in the temperature range of 60-65oC, thermostability is restored with the increased
concentration of BTL2 and W235A. In other words, aggregation of this lipase resists ther-
mal denaturation and contributes to the thermostability of the wild-type lipase and W235A
mutation does not affect the positive correlation of the aggregation and thermostability in
BTL2. However, the other mutant, W212A does not yield different thermostability pro-
files at different concentrations. In other words, high concentration of W212A is failed to
restore the activity compared to low concentration. This observation together with the de-
creased thermostability ofW212Amay in part explaining the decreased stability ofW212A
mutant by the defect in the aggregation behavior. In the absence of aggregation, W212A
is likely to be more susceptible to thermal denaturation. Particularly, this discrepancy in
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Figure 5.10:
Effects of Aggregation on Thermostability. The lipases are incubated for 30 minutes at
the corresponding temperatures and the assays are performed after serial dilutions to the
incubated samples such that all lipase assays contain 10 nm of each lipase, 200 μM of
4-MU-caprylate and 0.1 M Tris-Cl at pH 8.0. Residual activity is reported as the
percentage of 45oC results. Two different concentration (1 μM, and 50 μM) is plotted.
Error bars represent deviations of the two independent experiments.
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the wild-type and W212A has enforced further tests to resolve between aggregates and
oligomers in these samples.
5.3.8 Dynamic Light Scattering
To confirm the inhibition of the aggregation behavior of BTL2 in case of W212A mu-
tant, dynamic light scattering (DLS) analyses of both lipases are carried out using 2.5 μM
concentration of lipase at 25oC. DLS is a rapid, non-invasive and reliable technique for de-
termination of the globular protein size and aggregation behavior by monitoring the scat-
tering intensity fluctuations and the correlations in the signal decay intensity [215–218].
Since intensity fluctuations are consequences of particle motion which are measured prop-
erly in the correlation analysis of the distribution of diffusion coefficients, this technique
provides rapid access to size information for the characterization of proteins and it is also
very sensitive to the presence of aggregates [218, 219]. Previously in a DLS analysis, the
hydrodynamic radius of BTL2 was found to be around 3-4 nm in its monomer form, pre-
viously [203]. Figure 4.12. shows the intensity and volume size distributions of BTL2
and W212A obtained from three measurements in this study. All of the distributions are
monomodal which is an indication of polydispersity. The peaks that have the largest area
are chosen to comment on the majority of the particles in the samples and the results of
three measurements are given in Table 5.2. The largest peak size (Rh) in BTL2 is around
72 nm in average, much larger than a monomer (3-4 nm). The width of this peak (CP) is
relatively larger and thus the polydispersity index (%CP/RH) is higher in BTL2. In other
words, majority of the particles (80%) found in BTL2 are polydisperse, i.e. aggregated.
But according to Table 5.2, W212A sample is dominated by the particles with the average
size of 3.89 nm, in agreement with the previous finding [203]. Moreover, the percentage of
these monomers in W212A is much higher (99%) than other particles. The width of these
peaks are very low which also shows the monodispersity with a PDI of < 10%. These
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Figure 5.11: Intensity and Volume Distributions of DLS Data.
findings confirms that the W212 is required for aggregation of BTL2 lipase.
As mentioned, the results are obtained from multimodal data for each measurements.
Nevertheless, single peaks with the largest area chosen for the monomodal analysis, other
particulate at different sizes and intensities are visible in the intensity-size distributions
in Figure 5.11. Intensity distribution of BTL2 is typical to a polydisperse sample, i.e.
relatively large particles at varying size and shape. In the intensity distribution of W212A
(Figure 5.11), the largest contribution is made by peaks that are very similar to BTL2,
nevertheless the percentage of these particles are very low in W212A samples. At first
these peaks may be considered as dirt or contaminating particles in the sample solution but
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Table 5.2: DLS Results.
nm %
RH CP CP/RH V
BTL2 71.65 ± 12.09 20.35 ± 4.74 28.40 79.66
W212A 3.89 ± 0.19 0.27 ± 0.03 6.94 98.83
these peaks are in very similar in size and shape to the ones observed for aggregated BTL2.
Additionally, the measured radius for these relatively large particles in W212A is too low
i.e. below micron range to be a dust particle. Thus, these peaks may correspond to the
similarly aggregated particles in BTL2 which indicates that a very small portion of particles
found inW212Amutant lipases are still aggregating even in the presence of a mutation that
restricts aggregation for the majority of particles. In this sense, the aggregation behavior
of BTL2 must be a complex mechanism which is likely to be dependent on not a single
residue but many other. Still W212A is a very effective mutation to suppress aggregation
of BTL2.
5.3.9 Effects of Metals on the Activity
Here, we have analyzed the effects of calcium and zinc on the activity of wild-type and
W212A mutant. Both of the metals are found in the crystal structure of open and closed
conformations [33,156]. Zinc is found to be required for the stability and activity of BTL2
whereas calcium has not significant affects [156]. Divalent cations like zinc zinc is also
found to affect the activity of other thermostable lipase through aggregation [220]. In this
regard, we show the effect of increasing calcium and zinc concentration on the activity of
wild-type and W212A (Figure 5.12). It seems that calcium decreases the activity of BTL2
whereas it is ineffective in case ofW212A (Figure 5.12). The negative effects of the zinc on
the lipase activity is retarded in W212A mutant. Considering that metals may promote the
aggregation of this lipase [220–222], we see that W212A mutant is significantly tolerant
to this aggregation. These results indicate that W212A mutant is a deformed in its zinc
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Figure 5.12:
Effects of Calcium and Zinc on Activity. The percent hydrolysis is shown in a
concentration gradient of Calcium and Zinc from 0.6 to 5.0 mM. The activity for
wild-type and mutant is set to 100% for the samples without Zn. All assays are performed
in 0.1M Tris buffer at pH 7.25.
domain so that the zinc does not have significant effects on the activity.
5.3.10 Molecular Dynamics
Dimers with Zinc
To understand the mechanism of W212 in the aggregation of BTL2, we have implemented
molecular dynamics (MD) simulations. We have used the crystal structure of the lipase
dimer in which both of the monomers are in closed conformation. We thought that the
crystal structure that is found in the dimer form (PDB ID: 1KU0) could be used to assess
the aggregation of BTL2. We have used 10 ns of simulations for wild-type and W212A
mutation and RMSD analysis of the simulations reflect an equilibration of all dimer struc-
tures with less than 1 A˚ (Figure 5.13). For all systems we do not see any movement of
the metal ions (2 Ca and 2 Zn) within the structure throughout 10 ns. Upon investigation
of the residue at the dimer interface, we have encountered two hydrogen bonds formed by
the backbone amide groups of two residues in chain A and the carbonyl oxygen groups of
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two complementary residues in chain B (Figure 5.14). The persistence of these hydrogen
bonds for all systems is shown in Figure 5.15. Evidently, the most strong pairing (HB
I) is the one between L285(NH) of chain A and T1235 (O) of chain B and the relatively
weaker one (HB II) is formed between L277 (NH) of chain A and G86 (O) of chain B.
Particularly HB I is persistent regardless of W212A mutation Figure 5.15. However, the
relatively weaker bond, HB II is destabilized in the case of W212A mutation. According to
molecular dynamics findings, we conclude that W212 is required for the stability of one of
the bonds at the dimer interface and this partial stabilization of the HB II could explain the
loss of aggregation in W212A mutant. W212 is located at the close proximity to the HB
II and alanine substitution at this position affects the backbone NH group configuration of
L277 residue which leads to dissociation of the HB II in case of this mutant. In this aspect,
W212 is a critical residue that hold the dimer together in 1KU0 structure and it is required
for aggregation. We have additionally performed molecular dynamics of the dimer systems
at 400K to see the effects of the temperature on the structure posed by W212A mutation
yet we have observed that at 400K, zinc ion, leaves its coordination shell and moves freely
in the wild-type dimer (Figure 5.16). This indeed corresponds to deformation of the tetra-
hedral zinc coordination which may be a result of parameters for the divalent zinc cation in
CHARMM force field which is used here. We have also encountered other cases that also
suffered from such deformations in similar zinc coordination sites in molecular dynamics
simulations [223]. To solve this movement of zinc, additional restraints may be introduced
on the system to prevent the deformation of the tetrahedral zinc coordination. Yet, it was
best not to put any restraints in our case since zinc ion is found at the dimer interface and
may influence the dimer interactions. In these regards, here we avoid drawing any other
conclusions other than Figure 5.16 related to high temperature simulations.
98
Figure 5.13:
RMSD of the Dimers. The backbone atoms (C, CA and N) are aligned to the minimized
structure and RMSD in Angstrom units is shown for wild-type dimer (black line) and
W212A mutant dimer for 10 ns simulations. The metals found in the crystal structures
(Ca and Zn) are included in these simulations and stayed in their initial configuration
without any restraints.
Figure 5.14:
Interactions at the Dimer Interface. Chain A is colored in silver and chain B is colored in
tan and two hydrogen bonds between backbone NH (L278) and O (G87) atoms and
between NH (L286) and O (T236) are shown.
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Figure 5.15:
Effects of Zn on Dimerization. (A) The dimer bonds given in Figure 5.14 are measured
throughout 10 ns simulations in the presence of both metals. Black line shows wild-type
and red line shows W212A mutant dimer. HB I corresponds to the hydrogen bond
between L278-NH and G86-O and HB II corresponds to the second hydrogen bond
between L285NH-T235-O. (B)Effects of Zn Absence on the Dimerization. Two bonds
that are shown in Figure 5.14 are measured similarly for the dimer structures that lacks Zn
ions. The simulations of the W212A mutant dimer that lack Zn ions are terminated when
a separation of the monomers are visible.
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Figure 5.16:
RMSD for Zn at High Temperatures.
Dimers without Zinc
After we see that 400K leads to deformation of the zinc coordination and in turn affects the
stability of the wild-type dimer, we decide to remove the zinc ion and see the effects of the
zinc absence on the wild-type and mutant dimer. Same hydrogen bonds are measured and
given in Figure 5.15. It is obvious that zinc absence is not detrimental alone to the stability
of dimer for 10 ns, indeed we see a partial dissociation of the same bond, HB II (Figure
5.15). Actually, zinc absence in the wild-type dimer creates a less drastic effect on HB II
than W212A mutation at the interface (Figure 5.15). However, the W212A mutant dimer
without Zn breaks both of the hydrogen bonds immediately and results in the dissociation
of the dimer structure (Figure 5.15). Yet neither zinc absence nor W212A mutation leads
to dissociation of the dimer in MD simulations.
5.3.11 Molecular Impacts of W212 and W235
W235A is particularly important for efficient hydrolysis of tributyrin. This impact of
W235A is investigated with respect to the location of its bulky side chain in the closed
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and open conformations and W235A is like might be critical for the binding of C4 TAG
on the lid and thus for the selectivity of C4. However, we have not found any discrepancy
in the thermoactivity and thermostability of W235A. On the other hand, for W212A mu-
tation, we have ended up with differential results than W235A or wild-type. more than we
expected. This mutation significantly affects the thermostability of wild-type lipase but we
also show that W212A is essential for the aggregation of BTL2. In this sense, decreased
thermoactivity and thermostability of W212A is likely to be a result of the loss of aggrega-
tion in W212A. In other words, W212A mutation stops aggregating which makes is more
susceptible to thermal inactivation. The basis of the impact of the W212A mutation on
the aggregation is further investigated in molecular dynamics using a dimer structure of
BTL2. The dimer is considered to be a simple model for the oligomerization of BTL2.
From MD analysis we show that W212A is particularly critical for the HB II yet we cannot
see a complete dissociation of the dimer structure in the case of W212A mutation for 10
ns. Together with this finding that we interpret our MD analysis such that W212A has
more acute effects on the one of the hydrogen bonds that hold dimer structure together.
However, according to DLS measurements, W212A mutation is shown to yield monomer
lipase molecules. It would be safe to conclude as that W212A is essential for oligomer-
ization/aggregation of BTL2 via destabilizing the hydrogens bonds at the interface. Apart
from these, we have seen that zinc absence in W212A mutation causes an immediate dis-
ruption of both of the hydrogen bonds at the dimer interface. In the experiments to test
the effects of zinc in the wild-type and W212A mutation, we found that wild-type lipase
activity is inhibited by the minute amount of zinc in the assays however, this inhibition is
retarded significantly for W212A mutation. This suggested that zinc promotes the aggre-
gation of this lipase and decreases the available activity site in the assays. Other thermoal-
kalophilic lipases contain zinc binding domain which is unique to this group among other
lipases. W212 is also found at the close proximity to zinc coordinating residues and addi-
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tionally, zinc absence was found to affect thermoactivity [156] and thermostability [161]
of B. stearothermophilus L1 lipase similar to the findings on W212A mutation. The recent
studies on other enzymes like cytochrome oxidase [222, 224] was shown to aggregate in
presence of divalent cations like zinc and secondary residues in the close proximity to zinc
coordination were also found to be critical for the aggregation processes in those enzymes.
In this sense, the role of zinc in the aggregation of thermoalkalophilic lipases could be
similar to this and W212 is most likely to be important in the aggregation of should also
be clarified i.e. whether W212 provides secondary interaction for zinc-induced aggrega-
tion. Overall we see that this residue might be essential not only being a lid tryptophan but
also for accompanying secondary interactions of zinc domain which could be the trigger
of the oligomerization and aggregation this lipase. In these aspects, W212A is a promising
mutation that inhibits the aggregation of BTL2 since this lipase aggregates through a very
similar mechanism of neurodegeranative protein pathogens in human, like amyloid fibrils
and prions [225].
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6 CONCLUSIONS
Protein engineering approaches can provide insights for designing novel lipases with im-
proved features. This thesis investigated the selectivity and stability of thermoalkalophilic
lipase from Bacillus thermocatenulatus via rational design approaches.
Understanding the chain-length selectivity of BTL2 will be useful for applications in
industrial sectors using short chain fatty acids because it has a distinct selectivity for short
chains. In a combined computational/experimental approach, we have analyzed and mod-
ified the chain-length selectivity of BTL2 in terms of catalytic preference. Our results
indicate that the L360F mutation will create the most selective enzyme for C4 over C8 fol-
lowed by F17A and V175A. Further selectivity gains can be achieved by considering mul-
tiple mutations, e.g. L360F in combination with F17A or V175A. Because each residue
interacts with a different chain, one expects the free energy changes in double mutations to
be given by the sum of single mutations.
Our design strategy is simply based on blocking of C8 acyl chains in mutants using in-
silico ES complexmodels of BTL2. The effect of mutations on C8 binding depends on their
relative positions in the cleft (i.e. sn-1, sn-2 and sn-3) and also their relative positions with
respect to C8 chains. Moreover, mutations are not in direct contact with the oxyanion hole,
and hence the specific activity changes for the mutations slightly influence the catalytic
preference. ES complex affinities have a much greater influence on the catalytic preference,
and these quantities can be estimated from SMD simulations easily. We note that restricting
the volume strategy worked only in some cases, while in some other cases, mutations
actually increased the affinity of C4, which was unexpected. This shows the complexity of
the problem and reinforces the importance of inspecting each case with the same rigor. In
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conclusion, we have proposed a novel approach to analyze and alter substrate selectivity of
enzymes in terms of relative changes in the binding free energies of ES and ES‡ complexes
determined from simulations and experiments. The approaches used in this study could be
applied to other lipases to modify their substrate selectivity and produce tailor-made fatty
acids.
A practical knowledge on how thermoalkalophilic lipases are stable at high tempera-
tures not only helps in obtaining insights to design novel lipases with desired stabilities
but also deepens our understanding of thermostability. Particularly, tryptophans in the lid
region of BTL2 are found to be involved in such critical roles. Here, W235A substitu-
tion was shown to lower chain-length selectivity i.e. tributyrin/tricaprylin activity whereas
W212A had no effects on that. On the other hand, W212A is shown to affect aggregation,
thermostability and thermoactivity of wild-type lipase, negatively. Aggregation of indus-
trially important enzymes like BTL2 is a major concern such that aggregation decreases
the solubility of the recombinant proteins and thus results in loss of yield of production.
Here, W211A mutant represents a promising mutation which is defective in aggregation
and thus increases solubility of BTL2. Yet, increased solubility of BTL2 comes with the
price in W211A such that it also decreases thermostability and thermoactivity. Industrial
conditions may require non-optimal conditions like high temperatures, although decrease
in optimum working temperatures of enzymatic processes may aid in lowering the en-
ergy consumption of the biocatalysis. Hence, the particular decrease in thermostability of
W211A mutation may not necessarily be a disadvantage.
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Figure A.1: DNA and Protein Molecular Weight Markers
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Figure A.2: CHARMM Parameters for Tributyrin
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Figure A.3: Cloning Vector Map
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Figure A.4: Expression Vector Map
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Figure A.5: Correlation Data
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Figure A.6: Cumulants-fit Data
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